| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cleft Lip | 93 | 2024 | 504 | 15.370 |
Why?
|
| Cleft Palate | 76 | 2024 | 587 | 10.050 |
Why?
|
| Hemangioma | 99 | 2024 | 727 | 7.640 |
Why?
|
| Lip | 32 | 2021 | 197 | 7.050 |
Why?
|
| Nose | 34 | 2021 | 519 | 5.170 |
Why?
|
| Craniosynostoses | 47 | 2019 | 412 | 4.250 |
Why?
|
| Arteriovenous Malformations | 51 | 2023 | 397 | 4.170 |
Why?
|
| Facial Asymmetry | 37 | 2013 | 172 | 3.630 |
Why?
|
| Vascular Malformations | 31 | 2023 | 464 | 3.420 |
Why?
|
| Velopharyngeal Insufficiency | 13 | 2022 | 102 | 2.900 |
Why?
|
| Rhinoplasty | 18 | 2021 | 238 | 2.830 |
Why?
|
| Oral Surgical Procedures | 11 | 2015 | 166 | 2.570 |
Why?
|
| Frontal Bone | 22 | 2016 | 105 | 2.490 |
Why?
|
| Surgery, Plastic | 37 | 2021 | 640 | 2.460 |
Why?
|
| Abnormalities, Multiple | 43 | 2017 | 1415 | 2.430 |
Why?
|
| Surgical Flaps | 26 | 2022 | 1666 | 2.070 |
Why?
|
| Capillaries | 15 | 2023 | 745 | 2.020 |
Why?
|
| Orbit | 22 | 2019 | 446 | 2.000 |
Why?
|
| Cephalometry | 33 | 2019 | 382 | 1.880 |
Why?
|
| Infant | 227 | 2024 | 36030 | 1.880 |
Why?
|
| Lymphatic Abnormalities | 14 | 2023 | 132 | 1.720 |
Why?
|
| Skull | 27 | 2012 | 815 | 1.690 |
Why?
|
| Child, Preschool | 217 | 2024 | 42034 | 1.650 |
Why?
|
| Craniofacial Abnormalities | 17 | 2016 | 315 | 1.610 |
Why?
|
| Palate, Soft | 9 | 2022 | 100 | 1.600 |
Why?
|
| Veins | 22 | 2021 | 765 | 1.590 |
Why?
|
| Osteotomy, Le Fort | 9 | 2019 | 93 | 1.580 |
Why?
|
| Forehead | 8 | 2016 | 74 | 1.490 |
Why?
|
| Craniofacial Dysostosis | 18 | 2016 | 74 | 1.420 |
Why?
|
| Skin Neoplasms | 54 | 2024 | 5797 | 1.400 |
Why?
|
| Facial Bones | 22 | 2016 | 205 | 1.390 |
Why?
|
| Optical Illusions | 2 | 2020 | 40 | 1.350 |
Why?
|
| Facial Neoplasms | 12 | 2015 | 125 | 1.340 |
Why?
|
| Face | 23 | 2020 | 1017 | 1.340 |
Why?
|
| Bone Transplantation | 30 | 2016 | 922 | 1.340 |
Why?
|
| Reoperation | 26 | 2021 | 4292 | 1.330 |
Why?
|
| Pierre Robin Syndrome | 9 | 2016 | 117 | 1.290 |
Why?
|
| Palate, Hard | 4 | 2020 | 58 | 1.280 |
Why?
|
| Acrocephalosyndactylia | 18 | 2015 | 90 | 1.240 |
Why?
|
| Vascular Neoplasms | 10 | 2024 | 167 | 1.210 |
Why?
|
| Child | 223 | 2024 | 79758 | 1.200 |
Why?
|
| Photogrammetry | 5 | 2021 | 77 | 1.110 |
Why?
|
| Maxillofacial Development | 13 | 2015 | 87 | 1.080 |
Why?
|
| Retrospective Studies | 145 | 2023 | 80301 | 0.990 |
Why?
|
| Hemangioma, Capillary | 7 | 2014 | 62 | 0.980 |
Why?
|
| Terminology as Topic | 15 | 2015 | 1534 | 0.970 |
Why?
|
| Anthropometry | 12 | 2021 | 1348 | 0.960 |
Why?
|
| Adoption | 2 | 2015 | 97 | 0.950 |
Why?
|
| Sclerotherapy | 9 | 2023 | 181 | 0.940 |
Why?
|
| Oral Fistula | 3 | 2020 | 13 | 0.930 |
Why?
|
| Nasal Septum | 3 | 2017 | 130 | 0.900 |
Why?
|
| Synostosis | 5 | 2009 | 43 | 0.900 |
Why?
|
| Mandible | 22 | 2015 | 749 | 0.890 |
Why?
|
| Infant, Newborn | 113 | 2024 | 26168 | 0.890 |
Why?
|
| Maxilla | 14 | 2016 | 490 | 0.880 |
Why?
|
| Male | 335 | 2024 | 359413 | 0.880 |
Why?
|
| Klippel-Trenaunay-Weber Syndrome | 5 | 2015 | 69 | 0.880 |
Why?
|
| Humans | 519 | 2024 | 760261 | 0.880 |
Why?
|
| Tongue | 7 | 2015 | 404 | 0.870 |
Why?
|
| Female | 329 | 2024 | 391011 | 0.820 |
Why?
|
| Nose Neoplasms | 5 | 2010 | 249 | 0.800 |
Why?
|
| Dermoid Cyst | 6 | 2010 | 92 | 0.800 |
Why?
|
| Cranial Sutures | 12 | 2014 | 92 | 0.800 |
Why?
|
| Parietal Bone | 11 | 2016 | 49 | 0.790 |
Why?
|
| Hallux | 1 | 2022 | 43 | 0.780 |
Why?
|
| Blood Vessels | 14 | 2012 | 1112 | 0.770 |
Why?
|
| Hemangioendothelioma | 10 | 2013 | 111 | 0.760 |
Why?
|
| Adolescent | 160 | 2024 | 87747 | 0.760 |
Why?
|
| Myositis Ossificans | 1 | 2022 | 77 | 0.750 |
Why?
|
| Pharynx | 7 | 2022 | 432 | 0.750 |
Why?
|
| Orthognathic Surgical Procedures | 3 | 2021 | 118 | 0.740 |
Why?
|
| Skin Diseases, Vascular | 4 | 2017 | 41 | 0.700 |
Why?
|
| Glomus Tumor | 9 | 2014 | 62 | 0.690 |
Why?
|
| Telangiectasis | 5 | 2017 | 77 | 0.680 |
Why?
|
| Ectodermal Dysplasia | 1 | 2020 | 106 | 0.670 |
Why?
|
| Craniotomy | 14 | 2016 | 741 | 0.670 |
Why?
|
| Imaging, Three-Dimensional | 9 | 2021 | 4044 | 0.670 |
Why?
|
| Photography | 7 | 2020 | 530 | 0.660 |
Why?
|
| Nose Deformities, Acquired | 1 | 2019 | 44 | 0.640 |
Why?
|
| Lipomatosis | 6 | 2017 | 112 | 0.640 |
Why?
|
| Speech | 4 | 2016 | 548 | 0.630 |
Why?
|
| Ear, External | 10 | 2014 | 164 | 0.630 |
Why?
|
| Plagiocephaly, Nonsynostotic | 2 | 2009 | 30 | 0.620 |
Why?
|
| Goldenhar Syndrome | 2 | 2017 | 39 | 0.610 |
Why?
|
| Upper Extremity | 4 | 2020 | 661 | 0.600 |
Why?
|
| CHARGE Syndrome | 1 | 2017 | 33 | 0.600 |
Why?
|
| Follow-Up Studies | 53 | 2020 | 39254 | 0.590 |
Why?
|
| Syndrome | 33 | 2016 | 3278 | 0.590 |
Why?
|
| Mouth Floor | 3 | 2008 | 38 | 0.580 |
Why?
|
| Osteogenesis, Distraction | 5 | 2016 | 227 | 0.570 |
Why?
|
| Palate | 6 | 2012 | 124 | 0.550 |
Why?
|
| Head Protective Devices | 4 | 2013 | 118 | 0.540 |
Why?
|
| Facial Muscles | 4 | 2020 | 159 | 0.530 |
Why?
|
| Osteotomy | 15 | 2016 | 835 | 0.530 |
Why?
|
| Lymphatic System | 5 | 2008 | 254 | 0.530 |
Why?
|
| Physicians, Women | 2 | 2014 | 492 | 0.530 |
Why?
|
| Specialties, Surgical | 2 | 2015 | 389 | 0.530 |
Why?
|
| Treatment Outcome | 54 | 2023 | 64947 | 0.530 |
Why?
|
| Hypertrophy | 5 | 2017 | 555 | 0.520 |
Why?
|
| Musculoskeletal Abnormalities | 3 | 2017 | 100 | 0.510 |
Why?
|
| Branchio-Oto-Renal Syndrome | 3 | 2011 | 25 | 0.500 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 3 | 5 | 2016 | 104 | 0.490 |
Why?
|
| Suture Techniques | 5 | 2011 | 788 | 0.490 |
Why?
|
| Eye | 1 | 2019 | 710 | 0.480 |
Why?
|
| History, 19th Century | 9 | 2015 | 720 | 0.480 |
Why?
|
| p120 GTPase Activating Protein | 6 | 2023 | 36 | 0.480 |
Why?
|
| Neovascularization, Pathologic | 15 | 2022 | 2641 | 0.470 |
Why?
|
| Mutation | 43 | 2019 | 29950 | 0.470 |
Why?
|
| Nevus, Blue | 4 | 2024 | 43 | 0.470 |
Why?
|
| Neoplastic Stem Cells | 10 | 2022 | 1347 | 0.470 |
Why?
|
| Ultrasonography, Prenatal | 10 | 2010 | 1745 | 0.460 |
Why?
|
| History, 20th Century | 13 | 2016 | 2777 | 0.460 |
Why?
|
| Glucose Transporter Type 1 | 5 | 2015 | 186 | 0.460 |
Why?
|
| Dura Mater | 3 | 2016 | 290 | 0.450 |
Why?
|
| Lymphedema | 7 | 2015 | 525 | 0.450 |
Why?
|
| Encephalocele | 3 | 2011 | 135 | 0.450 |
Why?
|
| Popliteal Vein | 1 | 2013 | 43 | 0.440 |
Why?
|
| Lymphangioma, Cystic | 4 | 2011 | 34 | 0.440 |
Why?
|
| Parotid Neoplasms | 2 | 2005 | 157 | 0.430 |
Why?
|
| Skin Abnormalities | 2 | 2016 | 59 | 0.420 |
Why?
|
| Torticollis | 4 | 2009 | 64 | 0.410 |
Why?
|
| Nasal Cavity | 1 | 2014 | 304 | 0.410 |
Why?
|
| Alveoloplasty | 3 | 2012 | 22 | 0.410 |
Why?
|
| Vascular Diseases | 6 | 2021 | 1180 | 0.400 |
Why?
|
| Zygoma | 4 | 2009 | 52 | 0.400 |
Why?
|
| Marriage | 1 | 2014 | 351 | 0.400 |
Why?
|
| Port-Wine Stain | 5 | 2017 | 33 | 0.380 |
Why?
|
| Postoperative Complications | 24 | 2020 | 15680 | 0.380 |
Why?
|
| Endothelial Cells | 14 | 2022 | 3537 | 0.380 |
Why?
|
| Maxillary Neoplasms | 2 | 2010 | 47 | 0.380 |
Why?
|
| Surgery, Oral | 4 | 2004 | 130 | 0.380 |
Why?
|
| Gigantism | 1 | 2010 | 15 | 0.370 |
Why?
|
| Attitude of Health Personnel | 3 | 2014 | 3870 | 0.370 |
Why?
|
| Diagnosis, Differential | 35 | 2020 | 12968 | 0.370 |
Why?
|
| Prenatal Diagnosis | 6 | 2016 | 1262 | 0.370 |
Why?
|
| DiGeorge Syndrome | 3 | 2011 | 185 | 0.370 |
Why?
|
| Propranolol | 4 | 2024 | 489 | 0.360 |
Why?
|
| Arteriovenous Fistula | 4 | 2023 | 314 | 0.360 |
Why?
|
| Age Factors | 23 | 2020 | 18415 | 0.350 |
Why?
|
| Amblyopia | 2 | 2010 | 150 | 0.350 |
Why?
|
| Skin | 17 | 2009 | 4468 | 0.350 |
Why?
|
| Soft Tissue Neoplasms | 6 | 2014 | 1151 | 0.350 |
Why?
|
| Fingers | 3 | 2014 | 505 | 0.350 |
Why?
|
| Saphenous Vein | 1 | 2013 | 538 | 0.350 |
Why?
|
| Temporal Bone | 4 | 2009 | 683 | 0.340 |
Why?
|
| Palatal Muscles | 3 | 2012 | 15 | 0.340 |
Why?
|
| Tomography, X-Ray Computed | 32 | 2019 | 20484 | 0.340 |
Why?
|
| Scalp Dermatoses | 2 | 2007 | 44 | 0.340 |
Why?
|
| Skull Base | 4 | 2007 | 291 | 0.330 |
Why?
|
| Lymphangioma | 6 | 2007 | 61 | 0.330 |
Why?
|
| Speech Intelligibility | 3 | 2014 | 79 | 0.330 |
Why?
|
| Mouth Abnormalities | 2 | 2011 | 19 | 0.330 |
Why?
|
| Speech Disorders | 1 | 2010 | 180 | 0.330 |
Why?
|
| Tissue and Organ Harvesting | 3 | 2011 | 377 | 0.330 |
Why?
|
| Pedigree | 33 | 2020 | 4577 | 0.320 |
Why?
|
| Gastrointestinal Neoplasms | 5 | 2024 | 951 | 0.320 |
Why?
|
| Osteogenesis | 13 | 2016 | 1271 | 0.310 |
Why?
|
| Adipose Tissue | 6 | 2018 | 3293 | 0.310 |
Why?
|
| Receptor, TIE-2 | 5 | 2016 | 177 | 0.310 |
Why?
|
| Epidural Neoplasms | 1 | 2008 | 23 | 0.310 |
Why?
|
| Neoplasms, Vascular Tissue | 3 | 2008 | 25 | 0.310 |
Why?
|
| Receptors, Fibroblast Growth Factor | 9 | 2004 | 191 | 0.310 |
Why?
|
| DNA Mutational Analysis | 17 | 2017 | 4109 | 0.310 |
Why?
|
| Radiography | 21 | 2015 | 6965 | 0.310 |
Why?
|
| Lipoma | 4 | 2017 | 292 | 0.300 |
Why?
|
| Hypertelorism | 5 | 2002 | 29 | 0.300 |
Why?
|
| Adult | 106 | 2023 | 219847 | 0.300 |
Why?
|
| Granuloma, Pyogenic | 4 | 2020 | 47 | 0.300 |
Why?
|
| Magnetic Resonance Imaging | 37 | 2020 | 36247 | 0.300 |
Why?
|
| Nasal Mucosa | 1 | 2011 | 413 | 0.300 |
Why?
|
| Sturge-Weber Syndrome | 1 | 2009 | 85 | 0.300 |
Why?
|
| Skin Transplantation | 6 | 2008 | 1083 | 0.300 |
Why?
|
| Twins, Dizygotic | 3 | 2005 | 236 | 0.290 |
Why?
|
| Glucocorticoids | 8 | 2010 | 2143 | 0.290 |
Why?
|
| Pleural Effusion | 3 | 2023 | 343 | 0.290 |
Why?
|
| Neck | 6 | 2012 | 730 | 0.290 |
Why?
|
| Facial Hemiatrophy | 3 | 2020 | 24 | 0.280 |
Why?
|
| Splints | 4 | 2016 | 107 | 0.280 |
Why?
|
| Interferon Regulatory Factors | 5 | 2019 | 260 | 0.280 |
Why?
|
| Wilms Tumor | 3 | 2017 | 376 | 0.280 |
Why?
|
| Subcutaneous Tissue | 4 | 2021 | 132 | 0.280 |
Why?
|
| Toes | 1 | 2008 | 209 | 0.280 |
Why?
|
| Reference Values | 9 | 2017 | 4920 | 0.280 |
Why?
|
| Cicatrix | 8 | 2016 | 781 | 0.280 |
Why?
|
| Genes, Dominant | 9 | 2009 | 863 | 0.280 |
Why?
|
| Scalp | 2 | 2022 | 389 | 0.270 |
Why?
|
| Pericytes | 4 | 2014 | 292 | 0.270 |
Why?
|
| MAP Kinase Kinase 1 | 2 | 2019 | 332 | 0.270 |
Why?
|
| Eponyms | 1 | 2006 | 14 | 0.270 |
Why?
|
| Neurocutaneous Syndromes | 1 | 2007 | 53 | 0.270 |
Why?
|
| Hamartoma | 2 | 2007 | 235 | 0.270 |
Why?
|
| Orthopedics | 1 | 2015 | 891 | 0.270 |
Why?
|
| Transcription Factor AP-2 | 4 | 2011 | 79 | 0.270 |
Why?
|
| Nasal Bone | 6 | 2011 | 57 | 0.270 |
Why?
|
| Occipital Bone | 5 | 2010 | 55 | 0.270 |
Why?
|
| Phenotype | 24 | 2020 | 16543 | 0.270 |
Why?
|
| Body Weights and Measures | 3 | 2017 | 208 | 0.270 |
Why?
|
| Professional-Family Relations | 1 | 2010 | 495 | 0.260 |
Why?
|
| Fetal Diseases | 5 | 2013 | 911 | 0.260 |
Why?
|
| Interferon-alpha | 10 | 2004 | 919 | 0.260 |
Why?
|
| Skin Ulcer | 1 | 2007 | 129 | 0.260 |
Why?
|
| Doxycycline | 1 | 2008 | 337 | 0.260 |
Why?
|
| Eye Abnormalities | 4 | 2014 | 241 | 0.260 |
Why?
|
| Genetic Predisposition to Disease | 17 | 2020 | 17766 | 0.260 |
Why?
|
| Oxidoreductases Acting on CH-NH Group Donors | 2 | 2002 | 61 | 0.250 |
Why?
|
| Evidence-Based Medicine | 2 | 2017 | 3696 | 0.250 |
Why?
|
| Lymphatic Vessels | 4 | 2019 | 358 | 0.250 |
Why?
|
| Cardiovascular Abnormalities | 1 | 2006 | 143 | 0.250 |
Why?
|
| Purpura, Thrombocytopenic | 2 | 2004 | 41 | 0.250 |
Why?
|
| Young Adult | 37 | 2023 | 58673 | 0.250 |
Why?
|
| Rare Diseases | 6 | 2022 | 619 | 0.250 |
Why?
|
| Alveolar Process | 5 | 2008 | 294 | 0.240 |
Why?
|
| Sex Distribution | 6 | 2017 | 2295 | 0.240 |
Why?
|
| Hypopituitarism | 1 | 2006 | 248 | 0.230 |
Why?
|
| Nevus | 3 | 2017 | 205 | 0.230 |
Why?
|
| Central Nervous System Vascular Malformations | 2 | 2006 | 140 | 0.230 |
Why?
|
| Corneal Transplantation | 1 | 2008 | 321 | 0.230 |
Why?
|
| Laryngeal Neoplasms | 1 | 2008 | 514 | 0.230 |
Why?
|
| Diseases in Twins | 3 | 2005 | 447 | 0.230 |
Why?
|
| Career Choice | 1 | 2010 | 755 | 0.220 |
Why?
|
| Sphenoid Bone | 2 | 2002 | 177 | 0.220 |
Why?
|
| Divorce | 2 | 2003 | 76 | 0.220 |
Why?
|
| Paraganglioma, Extra-Adrenal | 2 | 2014 | 45 | 0.220 |
Why?
|
| Embolization, Therapeutic | 8 | 2011 | 1411 | 0.220 |
Why?
|
| Endothelium, Vascular | 13 | 2016 | 4437 | 0.220 |
Why?
|
| Ear Diseases | 1 | 2005 | 177 | 0.220 |
Why?
|
| Ephrin-B1 | 3 | 2008 | 24 | 0.220 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 2 | 8 | 2010 | 208 | 0.220 |
Why?
|
| Leg | 6 | 2017 | 1091 | 0.210 |
Why?
|
| Cartilage | 5 | 2002 | 806 | 0.210 |
Why?
|
| Mandibulofacial Dysostosis | 4 | 2009 | 36 | 0.210 |
Why?
|
| Malocclusion | 6 | 2011 | 131 | 0.210 |
Why?
|
| Germany | 4 | 2010 | 875 | 0.210 |
Why?
|
| Boston | 11 | 2022 | 9282 | 0.210 |
Why?
|
| Germ-Line Mutation | 6 | 2020 | 1843 | 0.210 |
Why?
|
| Tongue Diseases | 1 | 2002 | 68 | 0.200 |
Why?
|
| Patient Selection | 2 | 2012 | 4276 | 0.200 |
Why?
|
| Incidence | 18 | 2017 | 21378 | 0.200 |
Why?
|
| Absorbable Implants | 2 | 2016 | 345 | 0.200 |
Why?
|
| Hemostatics | 2 | 2011 | 243 | 0.200 |
Why?
|
| Endoscopy | 5 | 2013 | 1841 | 0.200 |
Why?
|
| Spinal Cord | 4 | 2011 | 1817 | 0.200 |
Why?
|
| Skin Diseases | 4 | 2020 | 1089 | 0.200 |
Why?
|
| Ophthalmology | 2 | 2008 | 549 | 0.200 |
Why?
|
| Neoplasms, Connective Tissue | 1 | 2021 | 36 | 0.200 |
Why?
|
| Heart Neoplasms | 1 | 2005 | 360 | 0.200 |
Why?
|
| Chromosome Aberrations | 3 | 2009 | 1767 | 0.200 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 5 | 2017 | 896 | 0.200 |
Why?
|
| Atenolol | 1 | 2022 | 99 | 0.200 |
Why?
|
| Head | 4 | 2012 | 922 | 0.190 |
Why?
|
| Chromosomes, Human, Pair 6 | 5 | 2011 | 375 | 0.190 |
Why?
|
| Mouth Mucosa | 4 | 2014 | 426 | 0.190 |
Why?
|
| Arm | 6 | 2017 | 583 | 0.190 |
Why?
|
| Exercise Therapy | 1 | 2008 | 920 | 0.180 |
Why?
|
| Anodontia | 1 | 2001 | 50 | 0.180 |
Why?
|
| Prognathism | 2 | 2014 | 26 | 0.180 |
Why?
|
| Tumor Suppressor Proteins | 5 | 2024 | 2804 | 0.180 |
Why?
|
| Neoplasm Regression, Spontaneous | 4 | 2008 | 46 | 0.180 |
Why?
|
| Severity of Illness Index | 12 | 2020 | 15827 | 0.180 |
Why?
|
| Vascular Surgical Procedures | 2 | 2009 | 1469 | 0.180 |
Why?
|
| Genetic Linkage | 14 | 2010 | 2381 | 0.180 |
Why?
|
| Bone and Bones | 9 | 2013 | 2560 | 0.170 |
Why?
|
| Receptor Protein-Tyrosine Kinases | 7 | 2004 | 1614 | 0.170 |
Why?
|
| Astigmatism | 3 | 2010 | 68 | 0.170 |
Why?
|
| Sternum | 2 | 2006 | 175 | 0.170 |
Why?
|
| Phosphatidylinositol 3-Kinases | 3 | 2015 | 2866 | 0.170 |
Why?
|
| Polymorphism, Single Nucleotide | 14 | 2019 | 15766 | 0.170 |
Why?
|
| Sarcoma, Kaposi | 2 | 2013 | 376 | 0.170 |
Why?
|
| Lymph Nodes | 3 | 2019 | 3491 | 0.170 |
Why?
|
| Down Syndrome | 2 | 2008 | 891 | 0.170 |
Why?
|
| Polymerase Chain Reaction | 10 | 2016 | 6067 | 0.170 |
Why?
|
| Stem Cells | 6 | 2015 | 3525 | 0.170 |
Why?
|
| Cohort Studies | 15 | 2017 | 41317 | 0.170 |
Why?
|
| Pregnancy | 21 | 2024 | 29725 | 0.170 |
Why?
|
| Esthetics | 1 | 2021 | 326 | 0.170 |
Why?
|
| Magnetic Resonance Angiography | 4 | 2014 | 1430 | 0.160 |
Why?
|
| Parent-Child Relations | 2 | 2003 | 759 | 0.160 |
Why?
|
| Erythema | 1 | 2020 | 262 | 0.160 |
Why?
|
| Ultrasonography | 6 | 2017 | 5960 | 0.160 |
Why?
|
| Prevalence | 7 | 2017 | 15687 | 0.160 |
Why?
|
| Proteus Syndrome | 3 | 2007 | 13 | 0.160 |
Why?
|
| Combined Modality Therapy | 10 | 2020 | 8551 | 0.160 |
Why?
|
| Hamartoma Syndrome, Multiple | 2 | 2012 | 114 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2000 | 231 | 0.160 |
Why?
|
| Prospective Studies | 17 | 2016 | 54263 | 0.160 |
Why?
|
| Genes | 3 | 2010 | 1845 | 0.160 |
Why?
|
| Adrenal Cortex Hormones | 4 | 2004 | 1870 | 0.150 |
Why?
|
| Immunohistochemistry | 7 | 2024 | 11064 | 0.150 |
Why?
|
| Chromosomes, Human, Pair 5 | 5 | 2003 | 385 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor A | 9 | 2019 | 3483 | 0.150 |
Why?
|
| Head and Neck Neoplasms | 8 | 2010 | 2880 | 0.150 |
Why?
|
| X-Ray Microtomography | 4 | 2012 | 444 | 0.150 |
Why?
|
| Anesthesia, Inhalation | 1 | 1999 | 220 | 0.150 |
Why?
|
| Orbital Neoplasms | 3 | 2007 | 221 | 0.150 |
Why?
|
| Prostheses and Implants | 4 | 2010 | 1272 | 0.150 |
Why?
|
| Fibrosarcoma | 3 | 2002 | 308 | 0.150 |
Why?
|
| Multipotent Stem Cells | 2 | 2010 | 200 | 0.150 |
Why?
|
| Cell Adhesion Molecules | 3 | 2010 | 1602 | 0.150 |
Why?
|
| Airway Obstruction | 4 | 2012 | 660 | 0.150 |
Why?
|
| Congenital Abnormalities | 4 | 2010 | 704 | 0.150 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-3 | 2 | 2009 | 119 | 0.140 |
Why?
|
| Receptor, EphB4 | 1 | 2017 | 39 | 0.140 |
Why?
|
| Image Enhancement | 1 | 2008 | 2877 | 0.140 |
Why?
|
| Disease Progression | 13 | 2024 | 13505 | 0.140 |
Why?
|
| Genetic Variation | 6 | 2020 | 6540 | 0.140 |
Why?
|
| Collagen | 5 | 2002 | 2635 | 0.140 |
Why?
|
| Heart Defects, Congenital | 5 | 2008 | 4668 | 0.140 |
Why?
|
| Skull Neoplasms | 2 | 2008 | 173 | 0.140 |
Why?
|
| Sex Factors | 8 | 2013 | 10530 | 0.140 |
Why?
|
| Rosaniline Dyes | 1 | 2016 | 48 | 0.140 |
Why?
|
| Neovascularization, Physiologic | 3 | 2014 | 1335 | 0.140 |
Why?
|
| Sclerosing Solutions | 3 | 2008 | 79 | 0.140 |
Why?
|
| Achondroplasia | 1 | 1996 | 28 | 0.140 |
Why?
|
| Protein-Tyrosine Kinases | 4 | 2004 | 2415 | 0.140 |
Why?
|
| Angiomatosis | 2 | 2007 | 46 | 0.140 |
Why?
|
| Facies | 3 | 2016 | 223 | 0.140 |
Why?
|
| Cheek | 3 | 2011 | 65 | 0.140 |
Why?
|
| Dermis | 1 | 2018 | 202 | 0.140 |
Why?
|
| Age Distribution | 4 | 2017 | 2893 | 0.140 |
Why?
|
| Esthetics, Dental | 1 | 2018 | 268 | 0.140 |
Why?
|
| Time Factors | 16 | 2017 | 40133 | 0.140 |
Why?
|
| Nuclear Proteins | 8 | 2014 | 5793 | 0.140 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-1 | 2 | 2011 | 558 | 0.130 |
Why?
|
| Hepatic Veins | 1 | 1996 | 111 | 0.130 |
Why?
|
| DNA | 7 | 2016 | 7236 | 0.130 |
Why?
|
| Anemia | 2 | 2015 | 1511 | 0.130 |
Why?
|
| Blepharoptosis | 3 | 2008 | 143 | 0.130 |
Why?
|
| Uvea | 1 | 1996 | 30 | 0.130 |
Why?
|
| Angiopoietin-1 | 3 | 2013 | 123 | 0.130 |
Why?
|
| History, 21st Century | 4 | 2016 | 1576 | 0.130 |
Why?
|
| Tissue Expansion Devices | 1 | 1997 | 156 | 0.130 |
Why?
|
| Bone Neoplasms | 2 | 2007 | 2532 | 0.130 |
Why?
|
| Bone Substitutes | 1 | 1998 | 236 | 0.130 |
Why?
|
| Dexamethasone | 4 | 2011 | 1928 | 0.130 |
Why?
|
| Enophthalmos | 2 | 1993 | 34 | 0.130 |
Why?
|
| Functional Laterality | 4 | 2009 | 2253 | 0.130 |
Why?
|
| Cerebral Veins | 3 | 2007 | 157 | 0.130 |
Why?
|
| Tissue Expansion | 1 | 1997 | 160 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gi-Go | 1 | 2016 | 88 | 0.130 |
Why?
|
| Periodontal Dressings | 1 | 1995 | 5 | 0.130 |
Why?
|
| Chromosomes, Human, Pair 16 | 3 | 2007 | 342 | 0.130 |
Why?
|
| Coloboma | 1 | 1996 | 59 | 0.130 |
Why?
|
| GTP-Binding Protein alpha Subunits | 1 | 2016 | 102 | 0.130 |
Why?
|
| Lymphangiosarcoma | 1 | 2015 | 14 | 0.130 |
Why?
|
| MAP Kinase Kinase Kinase 3 | 1 | 2015 | 17 | 0.130 |
Why?
|
| Jugular Veins | 1 | 1996 | 211 | 0.130 |
Why?
|
| Cadherins | 1 | 2020 | 898 | 0.130 |
Why?
|
| Hepatic Artery | 1 | 1996 | 230 | 0.120 |
Why?
|
| GTP-Binding Protein alpha Subunits, Gq-G11 | 1 | 2016 | 143 | 0.120 |
Why?
|
| Arteries | 4 | 1994 | 1126 | 0.120 |
Why?
|
| Aortic Coarctation | 2 | 2008 | 282 | 0.120 |
Why?
|
| Wounds and Injuries | 4 | 2012 | 2477 | 0.120 |
Why?
|
| Antigens, CD | 4 | 2020 | 4002 | 0.120 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2008 | 3335 | 0.120 |
Why?
|
| Angiogenesis Inhibitors | 5 | 2010 | 2047 | 0.120 |
Why?
|
| Rabbits | 7 | 2016 | 4773 | 0.120 |
Why?
|
| Lower Extremity Deformities, Congenital | 1 | 2014 | 12 | 0.120 |
Why?
|
| Arnold-Chiari Malformation | 1 | 1996 | 158 | 0.120 |
Why?
|
| Chromosome Mapping | 15 | 2004 | 4625 | 0.120 |
Why?
|
| Insulin-Like Growth Factor II | 2 | 2008 | 268 | 0.120 |
Why?
|
| Linkage Disequilibrium | 7 | 2007 | 1996 | 0.120 |
Why?
|
| Dandy-Walker Syndrome | 1 | 1994 | 45 | 0.120 |
Why?
|
| Facial Paralysis | 2 | 1998 | 345 | 0.120 |
Why?
|
| Gastrointestinal Diseases | 2 | 2005 | 1189 | 0.120 |
Why?
|
| RNA, Messenger | 14 | 2016 | 12762 | 0.120 |
Why?
|
| Integrin alpha6 | 1 | 2014 | 30 | 0.120 |
Why?
|
| Foreign-Body Migration | 1 | 1996 | 218 | 0.120 |
Why?
|
| Monitoring, Intraoperative | 1 | 2001 | 941 | 0.120 |
Why?
|
| Sequence Deletion | 6 | 2008 | 1493 | 0.120 |
Why?
|
| E-Selectin | 2 | 2012 | 576 | 0.120 |
Why?
|
| Speech Therapy | 1 | 2014 | 57 | 0.120 |
Why?
|
| Receptors, FSH | 1 | 2014 | 29 | 0.120 |
Why?
|
| Intracranial Hypertension | 1 | 1996 | 193 | 0.120 |
Why?
|
| Databases, Factual | 6 | 2017 | 8018 | 0.120 |
Why?
|
| Syndactyly | 1 | 2014 | 71 | 0.120 |
Why?
|
| Fascia | 2 | 2014 | 142 | 0.120 |
Why?
|
| Clinical Coding | 1 | 2015 | 181 | 0.120 |
Why?
|
| Genetic Heterogeneity | 4 | 2014 | 724 | 0.110 |
Why?
|
| Subcutaneous Fat | 1 | 2017 | 393 | 0.110 |
Why?
|
| Postoperative Period | 1 | 2019 | 1821 | 0.110 |
Why?
|
| Folic Acid | 2 | 2010 | 1309 | 0.110 |
Why?
|
| Intubation, Intratracheal | 3 | 2010 | 1328 | 0.110 |
Why?
|
| Cleidocranial Dysplasia | 3 | 1999 | 18 | 0.110 |
Why?
|
| Transcription Factors | 10 | 2019 | 12100 | 0.110 |
Why?
|
| Scoliosis | 2 | 2010 | 733 | 0.110 |
Why?
|
| Glycoproteins | 4 | 2018 | 2208 | 0.110 |
Why?
|
| Oral Hemorrhage | 2 | 2011 | 24 | 0.110 |
Why?
|
| Molecular Sequence Data | 19 | 2013 | 17628 | 0.110 |
Why?
|
| Sleep Apnea, Obstructive | 3 | 2015 | 1859 | 0.110 |
Why?
|
| Chondrodysplasia Punctata | 1 | 2013 | 10 | 0.110 |
Why?
|
| Family Health | 9 | 2005 | 1258 | 0.110 |
Why?
|
| Mutation, Missense | 5 | 2016 | 2563 | 0.110 |
Why?
|
| Enhancer Elements, Genetic | 1 | 2020 | 1356 | 0.110 |
Why?
|
| Leg Length Inequality | 1 | 2013 | 56 | 0.110 |
Why?
|
| Recombinant Proteins | 11 | 2012 | 6543 | 0.110 |
Why?
|
| Mice, Nude | 7 | 2014 | 3605 | 0.110 |
Why?
|
| Hyperemesis Gravidarum | 1 | 2013 | 23 | 0.110 |
Why?
|
| Wound Healing | 10 | 2012 | 2786 | 0.110 |
Why?
|
| Bleomycin | 1 | 2014 | 496 | 0.110 |
Why?
|
| Bone Plates | 1 | 1996 | 465 | 0.110 |
Why?
|
| Vitamin K Deficiency | 1 | 2013 | 24 | 0.110 |
Why?
|
| Speech Articulation Tests | 1 | 2012 | 4 | 0.110 |
Why?
|
| Hospitals, Pediatric | 3 | 2015 | 1853 | 0.110 |
Why?
|
| Osteolysis, Essential | 1 | 2013 | 30 | 0.110 |
Why?
|
| Minerals | 3 | 1985 | 283 | 0.110 |
Why?
|
| Uniparental Disomy | 1 | 2013 | 45 | 0.110 |
Why?
|
| Inlays | 1 | 2012 | 8 | 0.110 |
Why?
|
| Uveal Neoplasms | 1 | 2016 | 339 | 0.110 |
Why?
|
| Job Satisfaction | 2 | 2010 | 539 | 0.110 |
Why?
|
| Neoplastic Syndromes, Hereditary | 2 | 2012 | 243 | 0.110 |
Why?
|
| Facial Nerve | 3 | 2005 | 277 | 0.110 |
Why?
|
| Sinus Pericranii | 1 | 2012 | 4 | 0.100 |
Why?
|
| Reproducibility of Results | 5 | 2018 | 20048 | 0.100 |
Why?
|
| Bone Diseases, Developmental | 2 | 2001 | 131 | 0.100 |
Why?
|
| Muscle Neoplasms | 1 | 2014 | 133 | 0.100 |
Why?
|
| Bone Screws | 1 | 1996 | 529 | 0.100 |
Why?
|
| Headache | 1 | 2020 | 1249 | 0.100 |
Why?
|
| Temporomandibular Joint | 3 | 2009 | 196 | 0.100 |
Why?
|
| Teratoma | 1 | 1995 | 403 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 8 | 2 | 2010 | 452 | 0.100 |
Why?
|
| Haplotypes | 8 | 2018 | 2764 | 0.100 |
Why?
|
| Genes, Homeobox | 1 | 1993 | 284 | 0.100 |
Why?
|
| Hand Deformities, Congenital | 3 | 2010 | 173 | 0.100 |
Why?
|
| MAP Kinase Signaling System | 2 | 2017 | 1483 | 0.100 |
Why?
|
| Bone Development | 2 | 2010 | 472 | 0.100 |
Why?
|
| Alleles | 10 | 2017 | 6900 | 0.100 |
Why?
|
| Massachusetts | 4 | 2017 | 8805 | 0.100 |
Why?
|
| Hearing Loss, Sensorineural | 5 | 2014 | 781 | 0.100 |
Why?
|
| Receptors, Somatotropin | 1 | 2012 | 58 | 0.100 |
Why?
|
| Risk Factors | 18 | 2014 | 74269 | 0.100 |
Why?
|
| Molecular Biology | 1 | 1996 | 581 | 0.100 |
Why?
|
| Polyethylene Glycols | 1 | 1998 | 1188 | 0.100 |
Why?
|
| Receptor, Fibroblast Growth Factor, Type 1 | 3 | 2010 | 256 | 0.100 |
Why?
|
| Multifactorial Inheritance | 1 | 2020 | 1351 | 0.100 |
Why?
|
| Foot Deformities, Congenital | 2 | 2010 | 59 | 0.100 |
Why?
|
| Zebrafish Proteins | 1 | 2018 | 1006 | 0.100 |
Why?
|
| Eyelids | 3 | 1997 | 277 | 0.100 |
Why?
|
| Exons | 7 | 2006 | 2391 | 0.100 |
Why?
|
| Nasal Cartilages | 1 | 2011 | 14 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 1 | 3 | 2013 | 635 | 0.100 |
Why?
|
| Vasoconstriction | 1 | 2014 | 592 | 0.100 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2019 | 1729 | 0.100 |
Why?
|
| Urogenital Abnormalities | 1 | 2014 | 256 | 0.100 |
Why?
|
| Brain Neoplasms | 4 | 2009 | 8984 | 0.100 |
Why?
|
| Bone Resorption | 3 | 2012 | 720 | 0.100 |
Why?
|
| Spain | 2 | 2014 | 487 | 0.100 |
Why?
|
| Orthopedic Procedures | 3 | 2015 | 1262 | 0.100 |
Why?
|
| Genotype | 11 | 2019 | 12959 | 0.100 |
Why?
|
| Cell Proliferation | 11 | 2019 | 10434 | 0.100 |
Why?
|
| Lower Extremity | 3 | 2021 | 1196 | 0.100 |
Why?
|
| Risk Assessment | 9 | 2017 | 24086 | 0.100 |
Why?
|
| Mosaicism | 3 | 2014 | 466 | 0.090 |
Why?
|
| Fetus | 3 | 2024 | 1859 | 0.090 |
Why?
|
| Recurrence | 6 | 2020 | 8487 | 0.090 |
Why?
|
| Methods | 8 | 1989 | 1075 | 0.090 |
Why?
|
| GTPase-Activating Proteins | 1 | 2014 | 475 | 0.090 |
Why?
|
| Thrombocytopenia | 5 | 2005 | 1174 | 0.090 |
Why?
|
| Cell Division | 7 | 2011 | 4462 | 0.090 |
Why?
|
| Genitalia, Male | 1 | 2011 | 87 | 0.090 |
Why?
|
| United States | 14 | 2020 | 72363 | 0.090 |
Why?
|
| Lymphatic Diseases | 1 | 2013 | 319 | 0.090 |
Why?
|
| Tantalum | 1 | 2011 | 54 | 0.090 |
Why?
|
| Animals | 41 | 2022 | 167940 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 10 | 3 | 2004 | 276 | 0.090 |
Why?
|
| Mandibular Condyle | 2 | 2002 | 115 | 0.090 |
Why?
|
| Genital Neoplasms, Male | 1 | 2011 | 68 | 0.090 |
Why?
|
| Middle Aged | 35 | 2020 | 220175 | 0.090 |
Why?
|
| Homeodomain Proteins | 4 | 2024 | 2414 | 0.090 |
Why?
|
| Turbinates | 1 | 2011 | 64 | 0.090 |
Why?
|
| Peripheral Vascular Diseases | 1 | 2014 | 515 | 0.090 |
Why?
|
| Giant Cell Tumors | 2 | 2002 | 90 | 0.090 |
Why?
|
| Catheter Ablation | 3 | 2011 | 2755 | 0.090 |
Why?
|
| Kidney Neoplasms | 2 | 2017 | 4312 | 0.090 |
Why?
|
| Transplantation, Autologous | 8 | 2012 | 2120 | 0.090 |
Why?
|
| Surgical Procedures, Operative | 1 | 2002 | 1919 | 0.090 |
Why?
|
| Audiometry | 1 | 2011 | 253 | 0.090 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2014 | 675 | 0.090 |
Why?
|
| Confidence Intervals | 2 | 2008 | 2932 | 0.090 |
Why?
|
| Ilium | 2 | 2008 | 154 | 0.090 |
Why?
|
| Cell Transdifferentiation | 1 | 2011 | 185 | 0.090 |
Why?
|
| Polyvinyls | 1 | 2011 | 154 | 0.090 |
Why?
|
| International Classification of Diseases | 1 | 2015 | 884 | 0.090 |
Why?
|
| Base Sequence | 13 | 2017 | 12447 | 0.090 |
Why?
|
| Exophthalmos | 2 | 2005 | 97 | 0.090 |
Why?
|
| Intraoperative Care | 1 | 1994 | 768 | 0.090 |
Why?
|
| Jaw Abnormalities | 4 | 1998 | 27 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 4 | 3 | 2002 | 377 | 0.090 |
Why?
|
| Myofibroma | 1 | 2010 | 45 | 0.090 |
Why?
|
| Stomach Neoplasms | 1 | 2020 | 1423 | 0.090 |
Why?
|
| Statistics as Topic | 3 | 2008 | 2363 | 0.090 |
Why?
|
| Pregnancy Complications, Cardiovascular | 2 | 2004 | 516 | 0.080 |
Why?
|
| Referral and Consultation | 4 | 2012 | 3598 | 0.080 |
Why?
|
| Biocompatible Materials | 1 | 1998 | 1689 | 0.080 |
Why?
|
| Meninges | 2 | 2005 | 197 | 0.080 |
Why?
|
| Micrognathism | 1 | 2009 | 63 | 0.080 |
Why?
|
| Lip Diseases | 1 | 1989 | 18 | 0.080 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2011 | 1484 | 0.080 |
Why?
|
| Amino Acid Sequence | 12 | 2011 | 13456 | 0.080 |
Why?
|
| Premedication | 1 | 2010 | 253 | 0.080 |
Why?
|
| Proline | 1 | 2011 | 457 | 0.080 |
Why?
|
| Nasal Obstruction | 1 | 2011 | 159 | 0.080 |
Why?
|
| Dissection | 2 | 2010 | 298 | 0.080 |
Why?
|
| Cysts | 1 | 2014 | 683 | 0.080 |
Why?
|
| Stomatitis | 1 | 2011 | 271 | 0.080 |
Why?
|
| Extremities | 2 | 2012 | 867 | 0.080 |
Why?
|
| Uvula | 1 | 2008 | 16 | 0.080 |
Why?
|
| Neonatal Screening | 2 | 2017 | 595 | 0.080 |
Why?
|
| Ear | 2 | 2002 | 172 | 0.080 |
Why?
|
| Registries | 4 | 2008 | 8449 | 0.080 |
Why?
|
| Sleep Apnea Syndromes | 1 | 1997 | 973 | 0.080 |
Why?
|
| Gene Expression Regulation, Neoplastic | 6 | 2010 | 8498 | 0.080 |
Why?
|
| Curettage | 1 | 2008 | 73 | 0.080 |
Why?
|
| Sensitivity and Specificity | 5 | 2016 | 14656 | 0.080 |
Why?
|
| Membrane Glycoproteins | 3 | 2006 | 3731 | 0.080 |
Why?
|
| Pregnancy Outcome | 4 | 2016 | 2906 | 0.080 |
Why?
|
| Gastrointestinal Hemorrhage | 3 | 2015 | 1130 | 0.080 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2014 | 1256 | 0.080 |
Why?
|
| Point Mutation | 4 | 1998 | 1594 | 0.080 |
Why?
|
| Neck Muscles | 1 | 2009 | 100 | 0.080 |
Why?
|
| North America | 1 | 2012 | 1282 | 0.080 |
Why?
|
| Introns | 4 | 2014 | 978 | 0.080 |
Why?
|
| Methylenetetrahydrofolate Reductase (NADPH2) | 3 | 2010 | 275 | 0.080 |
Why?
|
| Abdomen | 1 | 1994 | 1124 | 0.080 |
Why?
|
| Endostatins | 2 | 2006 | 168 | 0.080 |
Why?
|
| Molecular Motor Proteins | 1 | 2008 | 105 | 0.080 |
Why?
|
| Sirolimus | 2 | 2015 | 1548 | 0.080 |
Why?
|
| New Hampshire | 1 | 2008 | 173 | 0.080 |
Why?
|
| Ear, Middle | 1 | 2010 | 337 | 0.080 |
Why?
|
| Calcium-Binding Proteins | 2 | 2011 | 1066 | 0.080 |
Why?
|
| Head Movements | 1 | 2009 | 152 | 0.070 |
Why?
|
| Embolism, Air | 1 | 1988 | 110 | 0.070 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2010 | 258 | 0.070 |
Why?
|
| Pregnancy Trimester, Second | 2 | 2016 | 732 | 0.070 |
Why?
|
| Gene Expression Regulation, Developmental | 5 | 2019 | 3601 | 0.070 |
Why?
|
| Macrostomia | 2 | 2005 | 6 | 0.070 |
Why?
|
| Endothelium, Lymphatic | 2 | 2024 | 63 | 0.070 |
Why?
|
| Exploratory Behavior | 1 | 2009 | 273 | 0.070 |
Why?
|
| Family | 4 | 2014 | 3189 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 9 | 4 | 2004 | 534 | 0.070 |
Why?
|
| Vein of Galen Malformations | 1 | 2008 | 58 | 0.070 |
Why?
|
| Placenta | 2 | 2007 | 1701 | 0.070 |
Why?
|
| Supine Position | 1 | 2008 | 205 | 0.070 |
Why?
|
| Agammaglobulinemia | 1 | 2009 | 172 | 0.070 |
Why?
|
| Adiposity | 1 | 2017 | 1851 | 0.070 |
Why?
|
| Receptors, Progesterone | 1 | 2012 | 1122 | 0.070 |
Why?
|
| Mouth Diseases | 1 | 2009 | 238 | 0.070 |
Why?
|
| Hematoma | 4 | 1980 | 769 | 0.070 |
Why?
|
| Arginine | 1 | 2011 | 934 | 0.070 |
Why?
|
| PTEN Phosphohydrolase | 3 | 2012 | 1115 | 0.070 |
Why?
|
| Social Behavior | 1 | 2014 | 1130 | 0.070 |
Why?
|
| Chi-Square Distribution | 4 | 2007 | 3466 | 0.070 |
Why?
|
| Immunoglobulin Variable Region | 1 | 2008 | 419 | 0.070 |
Why?
|
| Myocytes, Smooth Muscle | 1 | 2011 | 685 | 0.070 |
Why?
|
| Orthotic Devices | 1 | 2008 | 129 | 0.070 |
Why?
|
| Hearing | 1 | 2011 | 501 | 0.070 |
Why?
|
| Vena Cava, Superior | 1 | 2008 | 197 | 0.070 |
Why?
|
| Morphogenesis | 1 | 2010 | 740 | 0.070 |
Why?
|
| Thoracic Duct | 1 | 2007 | 64 | 0.070 |
Why?
|
| Myosin Heavy Chains | 1 | 2008 | 402 | 0.070 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 1137 | 0.070 |
Why?
|
| Chromosomes, Human, Pair 2 | 2 | 2004 | 313 | 0.070 |
Why?
|
| Case-Control Studies | 8 | 2016 | 22041 | 0.070 |
Why?
|
| Lod Score | 6 | 2010 | 602 | 0.070 |
Why?
|
| Gene Frequency | 4 | 2016 | 3605 | 0.070 |
Why?
|
| Liver Neoplasms | 2 | 2007 | 4317 | 0.070 |
Why?
|
| Glottis | 1 | 2008 | 214 | 0.070 |
Why?
|
| Mandibular Neoplasms | 2 | 1999 | 130 | 0.070 |
Why?
|
| Umbilical Cord | 1 | 2007 | 181 | 0.070 |
Why?
|
| Chromosomes, Human, X | 1 | 2008 | 320 | 0.070 |
Why?
|
| Genes, Recessive | 1 | 2009 | 626 | 0.070 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2007 | 56 | 0.070 |
Why?
|
| Delivery of Health Care | 1 | 2004 | 5324 | 0.070 |
Why?
|
| Chylothorax | 1 | 2007 | 83 | 0.070 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2011 | 1655 | 0.070 |
Why?
|
| Maxillofacial Abnormalities | 1 | 2006 | 22 | 0.070 |
Why?
|
| Muscle, Skeletal | 3 | 2014 | 4923 | 0.070 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2008 | 218 | 0.070 |
Why?
|
| Logistic Models | 3 | 2012 | 13311 | 0.070 |
Why?
|
| Oxacillin | 1 | 1985 | 41 | 0.070 |
Why?
|
| Penicillin G | 1 | 1985 | 41 | 0.070 |
Why?
|
| Hydroxamic Acids | 1 | 2009 | 482 | 0.070 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2013 | 2895 | 0.070 |
Why?
|
| Genetic Association Studies | 4 | 2020 | 2716 | 0.070 |
Why?
|
| Cranial Fossa, Posterior | 1 | 2006 | 135 | 0.070 |
Why?
|
| Receptors, Androgen | 1 | 2012 | 1075 | 0.070 |
Why?
|
| Physicians | 1 | 2024 | 4590 | 0.060 |
Why?
|
| Knee Joint | 1 | 2014 | 1662 | 0.060 |
Why?
|
| Mouth | 2 | 2006 | 380 | 0.060 |
Why?
|
| Brain | 7 | 2024 | 26912 | 0.060 |
Why?
|
| Renal Artery Obstruction | 1 | 2007 | 224 | 0.060 |
Why?
|
| Genes, Wilms Tumor | 1 | 2005 | 92 | 0.060 |
Why?
|
| Picibanil | 1 | 2005 | 10 | 0.060 |
Why?
|
| Angiography | 4 | 2009 | 1605 | 0.060 |
Why?
|
| Pilot Projects | 1 | 2018 | 8553 | 0.060 |
Why?
|
| Korean War | 1 | 2004 | 6 | 0.060 |
Why?
|
| Protease Inhibitors | 1 | 2009 | 755 | 0.060 |
Why?
|
| Patient Care Team | 4 | 2002 | 2510 | 0.060 |
Why?
|
| Hernia, Diaphragmatic | 1 | 2006 | 246 | 0.060 |
Why?
|
| Cell Differentiation | 6 | 2015 | 11480 | 0.060 |
Why?
|
| Shoulder | 3 | 1995 | 299 | 0.060 |
Why?
|
| Korea | 1 | 2004 | 96 | 0.060 |
Why?
|
| Mice | 15 | 2022 | 81216 | 0.060 |
Why?
|
| Neoplasm Staging | 3 | 2013 | 11141 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 5 | 2017 | 4717 | 0.060 |
Why?
|
| Facial Injuries | 4 | 1999 | 190 | 0.060 |
Why?
|
| Biological Evolution | 1 | 2010 | 1074 | 0.060 |
Why?
|
| ras GTPase-Activating Proteins | 1 | 2005 | 93 | 0.060 |
Why?
|
| Injections, Intralesional | 1 | 2005 | 278 | 0.060 |
Why?
|
| Eye Infections | 1 | 2005 | 62 | 0.060 |
Why?
|
| Longitudinal Studies | 3 | 2017 | 14482 | 0.060 |
Why?
|
| Antibodies, Monoclonal, Murine-Derived | 2 | 2024 | 693 | 0.060 |
Why?
|
| Founder Effect | 1 | 2005 | 186 | 0.060 |
Why?
|
| Brain Injuries | 1 | 1996 | 2044 | 0.060 |
Why?
|
| Cerebral Angiography | 4 | 2012 | 1272 | 0.060 |
Why?
|
| Pharyngeal Muscles | 2 | 2011 | 81 | 0.060 |
Why?
|
| Epistasis, Genetic | 2 | 2018 | 350 | 0.060 |
Why?
|
| Tongue Neoplasms | 3 | 2002 | 183 | 0.060 |
Why?
|
| MSX1 Transcription Factor | 2 | 2020 | 53 | 0.060 |
Why?
|
| Ligation | 1 | 2005 | 448 | 0.060 |
Why?
|
| Intracranial Arteriovenous Malformations | 2 | 1998 | 367 | 0.060 |
Why?
|
| Activator Appliances | 1 | 2003 | 2 | 0.060 |
Why?
|
| Heterozygote | 2 | 2013 | 2797 | 0.060 |
Why?
|
| Radiography, Panoramic | 2 | 2001 | 118 | 0.060 |
Why?
|
| Orthodontics, Interceptive | 1 | 2003 | 8 | 0.060 |
Why?
|
| Receptors, Estrogen | 1 | 2012 | 2202 | 0.060 |
Why?
|
| Palatal Obturators | 1 | 2003 | 8 | 0.060 |
Why?
|
| Cervical Vertebrae | 2 | 2008 | 978 | 0.060 |
Why?
|
| Wnt Proteins | 1 | 2008 | 718 | 0.060 |
Why?
|
| Statistics, Nonparametric | 3 | 2011 | 2852 | 0.060 |
Why?
|
| Membrane Proteins | 3 | 2020 | 7854 | 0.060 |
Why?
|
| Spine | 1 | 2011 | 1111 | 0.060 |
Why?
|
| Iliac Artery | 1 | 2005 | 344 | 0.060 |
Why?
|
| Thoracic Vertebrae | 1 | 2008 | 597 | 0.060 |
Why?
|
| Pediatrics | 1 | 1998 | 3587 | 0.060 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2011 | 4573 | 0.050 |
Why?
|
| Neural Cell Adhesion Molecules | 1 | 2003 | 121 | 0.050 |
Why?
|
| Lung | 1 | 2022 | 9989 | 0.050 |
Why?
|
| Developmental Disabilities | 1 | 2012 | 1504 | 0.050 |
Why?
|
| Pregnancy, Multiple | 1 | 2004 | 215 | 0.050 |
Why?
|
| Trisomy | 1 | 2004 | 260 | 0.050 |
Why?
|
| Hemangiosarcoma | 2 | 2008 | 218 | 0.050 |
Why?
|
| Adipogenesis | 1 | 2006 | 358 | 0.050 |
Why?
|
| Choristoma | 1 | 2005 | 207 | 0.050 |
Why?
|
| Laser Coagulation | 1 | 2005 | 327 | 0.050 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2004 | 313 | 0.050 |
Why?
|
| Hydrops Fetalis | 1 | 2023 | 109 | 0.050 |
Why?
|
| Hearing Loss | 1 | 2010 | 780 | 0.050 |
Why?
|
| Acid Phosphatase | 1 | 1983 | 139 | 0.050 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2004 | 1304 | 0.050 |
Why?
|
| Uterine Hemorrhage | 1 | 2004 | 242 | 0.050 |
Why?
|
| Vulva | 1 | 2023 | 82 | 0.050 |
Why?
|
| Proteins | 3 | 2006 | 6030 | 0.050 |
Why?
|
| Heart Failure | 1 | 2007 | 11835 | 0.050 |
Why?
|
| Matrix Metalloproteinases | 1 | 2005 | 392 | 0.050 |
Why?
|
| DNA-Binding Proteins | 2 | 2005 | 9590 | 0.050 |
Why?
|
| Physical Examination | 4 | 2010 | 1244 | 0.050 |
Why?
|
| Edema | 2 | 2005 | 772 | 0.050 |
Why?
|
| Atrophy | 1 | 2007 | 1625 | 0.050 |
Why?
|
| Labor Presentation | 1 | 2002 | 55 | 0.050 |
Why?
|
| Polysomnography | 3 | 2015 | 1817 | 0.050 |
Why?
|
| Disease Models, Animal | 6 | 2012 | 18134 | 0.050 |
Why?
|
| Genomic Imprinting | 1 | 2004 | 330 | 0.050 |
Why?
|
| Osteochondrodysplasias | 2 | 1999 | 182 | 0.050 |
Why?
|
| Twins, Monozygotic | 2 | 1997 | 469 | 0.050 |
Why?
|
| Respiratory Insufficiency | 3 | 2008 | 1228 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2008 | 2668 | 0.050 |
Why?
|
| Probability | 1 | 2008 | 2476 | 0.050 |
Why?
|
| Antineoplastic Agents | 6 | 2011 | 13629 | 0.050 |
Why?
|
| Spinal Neoplasms | 1 | 2009 | 716 | 0.050 |
Why?
|
| Neuroblastoma | 1 | 2010 | 1252 | 0.050 |
Why?
|
| Cell Movement | 5 | 2019 | 5206 | 0.050 |
Why?
|
| Branchial Region | 1 | 2002 | 35 | 0.050 |
Why?
|
| Aortic Aneurysm | 1 | 2007 | 646 | 0.050 |
Why?
|
| Primary Health Care | 1 | 1998 | 4649 | 0.050 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2005 | 323 | 0.050 |
Why?
|
| Proto-Oncogene Proteins | 3 | 2019 | 4494 | 0.050 |
Why?
|
| Fibroblast Growth Factor 2 | 5 | 2005 | 590 | 0.050 |
Why?
|
| Odds Ratio | 2 | 2004 | 9712 | 0.050 |
Why?
|
| Osteoblasts | 4 | 2012 | 1142 | 0.050 |
Why?
|
| NF-kappa B | 1 | 2010 | 2486 | 0.050 |
Why?
|
| Belgium | 2 | 2016 | 118 | 0.050 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2004 | 2494 | 0.050 |
Why?
|
| Balsams | 1 | 2021 | 6 | 0.050 |
Why?
|
| Tooth Abnormalities | 1 | 2001 | 56 | 0.050 |
Why?
|
| Mandibular Diseases | 1 | 2002 | 119 | 0.050 |
Why?
|
| Ascites | 1 | 2023 | 338 | 0.050 |
Why?
|
| Hemangioblastoma | 1 | 2002 | 63 | 0.050 |
Why?
|
| Gene Knockdown Techniques | 2 | 2018 | 1617 | 0.050 |
Why?
|
| Cell Separation | 3 | 2013 | 1720 | 0.050 |
Why?
|
| Neurologic Examination | 2 | 2009 | 916 | 0.050 |
Why?
|
| Comorbidity | 3 | 2017 | 10552 | 0.050 |
Why?
|
| Thumb | 2 | 2001 | 232 | 0.050 |
Why?
|
| Blindness | 2 | 2005 | 582 | 0.050 |
Why?
|
| Burnout, Professional | 1 | 2010 | 703 | 0.050 |
Why?
|
| Platelet Count | 1 | 2004 | 777 | 0.050 |
Why?
|
| Glucuronidase | 1 | 1983 | 203 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 1988 | 1186 | 0.050 |
Why?
|
| Compression Bandages | 1 | 2020 | 14 | 0.050 |
Why?
|
| Platelet Transfusion | 1 | 2004 | 294 | 0.050 |
Why?
|
| Isoxsuprine | 1 | 1980 | 2 | 0.050 |
Why?
|
| Twins | 1 | 2002 | 339 | 0.050 |
Why?
|
| Genetics | 1 | 2002 | 114 | 0.050 |
Why?
|
| Keratosis | 2 | 2015 | 80 | 0.050 |
Why?
|
| Basement Membrane | 2 | 1999 | 348 | 0.050 |
Why?
|
| Bicuspid | 1 | 2001 | 69 | 0.050 |
Why?
|
| Tracheostomy | 1 | 2005 | 425 | 0.050 |
Why?
|
| Blood Flow Velocity | 2 | 2007 | 1375 | 0.050 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 1981 | 72 | 0.050 |
Why?
|
| Cross-Sectional Studies | 4 | 2017 | 25928 | 0.050 |
Why?
|
| Tacrolimus Binding Proteins | 1 | 2002 | 193 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2002 | 334 | 0.050 |
Why?
|
| Transfection | 4 | 2013 | 5782 | 0.050 |
Why?
|
| Cells, Cultured | 7 | 2019 | 18968 | 0.050 |
Why?
|
| Fibrinogen | 1 | 2004 | 887 | 0.050 |
Why?
|
| Neoplasms, Multiple Primary | 2 | 2009 | 586 | 0.050 |
Why?
|
| Acoustic Impedance Tests | 2 | 2011 | 110 | 0.050 |
Why?
|
| Regression Analysis | 2 | 2007 | 6361 | 0.040 |
Why?
|
| Fatal Outcome | 1 | 2005 | 1833 | 0.040 |
Why?
|
| Interviews as Topic | 2 | 2006 | 2656 | 0.040 |
Why?
|
| Povidone | 1 | 1980 | 30 | 0.040 |
Why?
|
| Bone Lengthening | 1 | 1980 | 19 | 0.040 |
Why?
|
| Microsatellite Repeats | 4 | 2004 | 786 | 0.040 |
Why?
|
| Mast Cells | 3 | 1994 | 1428 | 0.040 |
Why?
|
| Metacarpus | 1 | 1980 | 36 | 0.040 |
Why?
|
| Analysis of Variance | 4 | 2011 | 6242 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2012 | 3561 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 4 | 2013 | 8945 | 0.040 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2010 | 1799 | 0.040 |
Why?
|
| Signal Transduction | 7 | 2016 | 23363 | 0.040 |
Why?
|
| Molar | 1 | 2001 | 156 | 0.040 |
Why?
|
| Povidone-Iodine | 1 | 1980 | 55 | 0.040 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2009 | 2755 | 0.040 |
Why?
|
| Hearing Loss, Conductive | 1 | 2001 | 159 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 3 | 2011 | 544 | 0.040 |
Why?
|
| Preoperative Care | 1 | 2009 | 2255 | 0.040 |
Why?
|
| Incisor | 1 | 2001 | 174 | 0.040 |
Why?
|
| Laminin | 2 | 2014 | 405 | 0.040 |
Why?
|
| Sodium Tetradecyl Sulfate | 1 | 1999 | 14 | 0.040 |
Why?
|
| Biopsy | 2 | 2017 | 6775 | 0.040 |
Why?
|
| Vertical Dimension | 2 | 2015 | 33 | 0.040 |
Why?
|
| Pregnancy Trimester, First | 1 | 2004 | 909 | 0.040 |
Why?
|
| In Situ Hybridization, Fluorescence | 4 | 2013 | 2500 | 0.040 |
Why?
|
| Infant, Low Birth Weight | 1 | 2004 | 858 | 0.040 |
Why?
|
| Achilles Tendon | 1 | 1982 | 179 | 0.040 |
Why?
|
| Seizures | 2 | 2007 | 2916 | 0.040 |
Why?
|
| Fetal Blood | 1 | 2006 | 1343 | 0.040 |
Why?
|
| Contracture | 1 | 1982 | 235 | 0.040 |
Why?
|
| Telangiectasia, Hereditary Hemorrhagic | 1 | 2001 | 141 | 0.040 |
Why?
|
| Carotid Stenosis | 1 | 2007 | 872 | 0.040 |
Why?
|
| Parity | 1 | 2002 | 925 | 0.040 |
Why?
|
| Gestational Age | 2 | 2002 | 3564 | 0.040 |
Why?
|
| Labor, Obstetric | 1 | 2002 | 321 | 0.040 |
Why?
|
| Receptors, Growth Factor | 1 | 2000 | 326 | 0.040 |
Why?
|
| Keloid | 2 | 1976 | 54 | 0.040 |
Why?
|
| Down-Regulation | 4 | 2013 | 2918 | 0.040 |
Why?
|
| Neoplasm Transplantation | 2 | 2014 | 2014 | 0.040 |
Why?
|
| Multigene Family | 2 | 2008 | 1079 | 0.040 |
Why?
|
| Neuroglia | 1 | 2005 | 944 | 0.040 |
Why?
|
| Limb Deformities, Congenital | 1 | 2000 | 136 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2014 | 3096 | 0.040 |
Why?
|
| Single-Blind Method | 2 | 2006 | 1577 | 0.040 |
Why?
|
| Equipment Design | 2 | 2016 | 3520 | 0.040 |
Why?
|
| Fourier Analysis | 1 | 2000 | 438 | 0.040 |
Why?
|
| Genetic Counseling | 2 | 2020 | 625 | 0.040 |
Why?
|
| Cell Communication | 3 | 2013 | 1642 | 0.040 |
Why?
|
| Dental Impression Materials | 1 | 1978 | 37 | 0.040 |
Why?
|
| Amputation, Traumatic | 1 | 1980 | 136 | 0.040 |
Why?
|
| Canada | 1 | 2004 | 2128 | 0.040 |
Why?
|
| RNA Interference | 3 | 2013 | 2846 | 0.040 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 1867 | 0.040 |
Why?
|
| Bone Regeneration | 2 | 2012 | 432 | 0.040 |
Why?
|
| Multiple Endocrine Neoplasia Type 2b | 1 | 1998 | 10 | 0.040 |
Why?
|
| Chemistry, Physical | 1 | 1998 | 154 | 0.040 |
Why?
|
| Thoracic Surgery | 1 | 2004 | 722 | 0.040 |
Why?
|
| Cranial Nerves | 1 | 1998 | 98 | 0.040 |
Why?
|
| Tumor Cells, Cultured | 3 | 2014 | 6131 | 0.040 |
Why?
|
| Random Allocation | 2 | 2014 | 2394 | 0.040 |
Why?
|
| Phosphoric Monoester Hydrolases | 1 | 2000 | 414 | 0.040 |
Why?
|
| Personal Satisfaction | 1 | 2002 | 643 | 0.040 |
Why?
|
| Chemical Phenomena | 1 | 1998 | 508 | 0.040 |
Why?
|
| rho GTP-Binding Proteins | 1 | 2019 | 277 | 0.040 |
Why?
|
| Aged | 11 | 2017 | 168995 | 0.040 |
Why?
|
| Genetic Markers | 5 | 2012 | 2608 | 0.040 |
Why?
|
| Melanoma | 2 | 2016 | 5695 | 0.040 |
Why?
|
| Neoplasm Proteins | 3 | 1999 | 3613 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2019 | 551 | 0.040 |
Why?
|
| Puberty | 2 | 2012 | 498 | 0.040 |
Why?
|
| Coculture Techniques | 2 | 2011 | 1340 | 0.040 |
Why?
|
| Tendons | 1 | 1981 | 552 | 0.040 |
Why?
|
| Vision Disorders | 1 | 2005 | 1084 | 0.040 |
Why?
|
| Viscosity | 1 | 1998 | 335 | 0.040 |
Why?
|
| Least-Squares Analysis | 1 | 1998 | 369 | 0.040 |
Why?
|
| Metalloendopeptidases | 1 | 1999 | 394 | 0.040 |
Why?
|
| Dermabrasion | 1 | 1977 | 16 | 0.040 |
Why?
|
| Nasopharynx | 2 | 2011 | 394 | 0.040 |
Why?
|
| Hirschsprung Disease | 1 | 1999 | 163 | 0.040 |
Why?
|
| Risk | 2 | 2012 | 9629 | 0.040 |
Why?
|
| Brain Diseases | 1 | 2006 | 1540 | 0.040 |
Why?
|
| Acanthosis Nigricans | 1 | 1996 | 47 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 3618 | 0.040 |
Why?
|
| Venous Pressure | 1 | 1996 | 57 | 0.040 |
Why?
|
| Interferon-beta | 1 | 1999 | 345 | 0.040 |
Why?
|
| Emotions | 1 | 2009 | 2730 | 0.030 |
Why?
|
| Amino Acid Substitution | 2 | 2013 | 1737 | 0.030 |
Why?
|
| Asymptomatic Diseases | 1 | 2020 | 582 | 0.030 |
Why?
|
| Egypt | 1 | 2016 | 98 | 0.030 |
Why?
|
| ATP-Binding Cassette Transporters | 1 | 2020 | 563 | 0.030 |
Why?
|
| Pulmonary Embolism | 1 | 2010 | 2544 | 0.030 |
Why?
|
| Databases as Topic | 2 | 2010 | 474 | 0.030 |
Why?
|
| Adipocytes | 2 | 2017 | 1179 | 0.030 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 463 | 0.030 |
Why?
|
| Cloning, Molecular | 3 | 2002 | 4172 | 0.030 |
Why?
|
| Phosphorylation | 4 | 2011 | 8314 | 0.030 |
Why?
|
| Cranial Sinuses | 1 | 1996 | 68 | 0.030 |
Why?
|
| Observer Variation | 2 | 2003 | 2596 | 0.030 |
Why?
|
| Karyotyping | 3 | 2004 | 1172 | 0.030 |
Why?
|
| Phosphoproteins | 2 | 2020 | 2441 | 0.030 |
Why?
|
| Culture | 1 | 2000 | 622 | 0.030 |
Why?
|
| History, Ancient | 1 | 2016 | 211 | 0.030 |
Why?
|
| Facial Dermatoses | 1 | 1977 | 85 | 0.030 |
Why?
|
| Ultrasonography, Doppler | 1 | 1998 | 466 | 0.030 |
Why?
|
| Nervous System Malformations | 1 | 1998 | 244 | 0.030 |
Why?
|
| Smallpox Vaccine | 1 | 1976 | 77 | 0.030 |
Why?
|
| Malocclusion, Angle Class III | 2 | 2014 | 38 | 0.030 |
Why?
|
| Length of Stay | 1 | 2010 | 6472 | 0.030 |
Why?
|
| Hyoid Bone | 1 | 2015 | 38 | 0.030 |
Why?
|
| Melena | 1 | 2015 | 32 | 0.030 |
Why?
|
| Bone Wires | 1 | 2016 | 124 | 0.030 |
Why?
|
| Matched-Pair Analysis | 2 | 2009 | 284 | 0.030 |
Why?
|
| Epidermis | 1 | 1999 | 529 | 0.030 |
Why?
|
| Sequence Alignment | 3 | 2009 | 2178 | 0.030 |
Why?
|
| Fibroblast Growth Factors | 1 | 2002 | 867 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 3 | 2010 | 10829 | 0.030 |
Why?
|
| Intestines | 1 | 2005 | 1907 | 0.030 |
Why?
|
| DNA Fingerprinting | 1 | 1996 | 111 | 0.030 |
Why?
|
| Databases, Genetic | 2 | 2017 | 1739 | 0.030 |
Why?
|
| Eustachian Tube | 1 | 1996 | 96 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2020 | 1181 | 0.030 |
Why?
|
| Neoplasm Recurrence, Local | 4 | 2001 | 9274 | 0.030 |
Why?
|
| Rats | 9 | 1999 | 23695 | 0.030 |
Why?
|
| Orthodontics, Corrective | 2 | 1987 | 77 | 0.030 |
Why?
|
| Necrosis | 5 | 1980 | 1612 | 0.030 |
Why?
|
| Delivery, Obstetric | 1 | 2002 | 933 | 0.030 |
Why?
|
| Growth Disorders | 2 | 2014 | 654 | 0.030 |
Why?
|
| Cell Survival | 3 | 2012 | 5796 | 0.030 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2005 | 1426 | 0.030 |
Why?
|
| High-Throughput Nucleotide Sequencing | 2 | 2020 | 3618 | 0.030 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2006 | 1634 | 0.030 |
Why?
|
| Secondary Prevention | 2 | 2012 | 1548 | 0.030 |
Why?
|
| Fracture Healing | 1 | 1998 | 438 | 0.030 |
Why?
|
| Hemangioma, Cavernous | 1 | 2015 | 107 | 0.030 |
Why?
|
| Dental Occlusion | 2 | 2003 | 53 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 1981 | 763 | 0.030 |
Why?
|
| Polymorphism, Restriction Fragment Length | 1 | 1996 | 761 | 0.030 |
Why?
|
| Prednisolone | 1 | 1996 | 328 | 0.030 |
Why?
|
| Ligands | 3 | 2009 | 3277 | 0.030 |
Why?
|
| Orbital Diseases | 2 | 1991 | 178 | 0.030 |
Why?
|
| Microtubule-Associated Proteins | 1 | 2000 | 1078 | 0.030 |
Why?
|
| Mesentery | 1 | 2015 | 203 | 0.030 |
Why?
|
| Family Planning Services | 1 | 1998 | 265 | 0.030 |
Why?
|
| Connective Tissue Diseases | 2 | 2009 | 286 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 3 | 2012 | 9196 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-1 | 1 | 2014 | 51 | 0.030 |
Why?
|
| RNA Splicing | 1 | 1999 | 914 | 0.030 |
Why?
|
| Up-Regulation | 4 | 2011 | 4127 | 0.030 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 1996 | 169 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2009 | 3526 | 0.030 |
Why?
|
| Four-Dimensional Computed Tomography | 1 | 2016 | 144 | 0.030 |
Why?
|
| Forecasting | 2 | 2015 | 2931 | 0.030 |
Why?
|
| Infant, Newborn, Diseases | 1 | 2000 | 592 | 0.030 |
Why?
|
| Intracranial Pressure | 1 | 1996 | 325 | 0.030 |
Why?
|
| Embryo, Mammalian | 1 | 2020 | 1667 | 0.030 |
Why?
|
| Larynx | 1 | 1999 | 492 | 0.030 |
Why?
|
| Flow Cytometry | 3 | 2016 | 5873 | 0.030 |
Why?
|
| In Situ Hybridization | 2 | 1999 | 1900 | 0.030 |
Why?
|
| Attitude to Health | 2 | 2000 | 2028 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2011 | 2473 | 0.030 |
Why?
|
| Mexican Americans | 1 | 2014 | 165 | 0.030 |
Why?
|
| Microscopy, Electron | 3 | 1997 | 2558 | 0.030 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2022 | 3584 | 0.030 |
Why?
|
| Drug Administration Schedule | 2 | 1999 | 4900 | 0.030 |
Why?
|
| Gene Order | 1 | 2013 | 169 | 0.030 |
Why?
|
| Ethmoid Bone | 1 | 1973 | 35 | 0.030 |
Why?
|
| Receptors, Adrenergic, beta-2 | 1 | 2014 | 213 | 0.030 |
Why?
|
| Graft Survival | 2 | 1981 | 3793 | 0.030 |
Why?
|
| Thorax | 2 | 1995 | 553 | 0.030 |
Why?
|
| Neural Tube Defects | 1 | 1995 | 254 | 0.030 |
Why?
|
| Cerebral Palsy | 1 | 1998 | 471 | 0.030 |
Why?
|
| Clinical Competence | 1 | 2009 | 4786 | 0.030 |
Why?
|
| Meningocele | 1 | 1973 | 46 | 0.030 |
Why?
|
| Diagnostic Errors | 2 | 2011 | 1266 | 0.030 |
Why?
|
| Neural Crest | 1 | 1995 | 279 | 0.030 |
Why?
|
| Models, Anatomic | 2 | 1994 | 682 | 0.030 |
Why?
|
| Blood Volume | 1 | 2014 | 550 | 0.030 |
Why?
|
| DNA Primers | 3 | 2003 | 2819 | 0.030 |
Why?
|
| Ethanol | 1 | 1999 | 1323 | 0.030 |
Why?
|
| Rotation | 2 | 2002 | 514 | 0.030 |
Why?
|
| Gene Expression | 1 | 2005 | 7592 | 0.030 |
Why?
|
| Bone Diseases | 1 | 1996 | 418 | 0.030 |
Why?
|
| Echocardiography | 1 | 2005 | 4980 | 0.030 |
Why?
|
| Chromosome Breakage | 1 | 2013 | 159 | 0.030 |
Why?
|
| Hemorrhage | 1 | 2005 | 3604 | 0.030 |
Why?
|
| Cardiopulmonary Bypass | 1 | 1978 | 1096 | 0.030 |
Why?
|
| Immunoglobulin Heavy Chains | 1 | 1995 | 649 | 0.030 |
Why?
|
| Clinical Protocols | 1 | 1998 | 1439 | 0.030 |
Why?
|
| 3' Untranslated Regions | 1 | 2014 | 514 | 0.030 |
Why?
|
| Axilla | 1 | 1995 | 618 | 0.030 |
Why?
|
| Transplantation, Homologous | 4 | 1981 | 4814 | 0.030 |
Why?
|
| Protein Structure, Tertiary | 3 | 2008 | 3800 | 0.020 |
Why?
|
| Antibodies, Blocking | 1 | 2012 | 241 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factor B | 1 | 2011 | 26 | 0.020 |
Why?
|
| Forkhead Transcription Factors | 1 | 2019 | 1613 | 0.020 |
Why?
|
| Vasoconstrictor Agents | 2 | 2014 | 651 | 0.020 |
Why?
|
| Cerebral Arteries | 1 | 1994 | 493 | 0.020 |
Why?
|
| Transplantation, Heterologous | 3 | 2014 | 2378 | 0.020 |
Why?
|
| Models, Genetic | 3 | 2012 | 3442 | 0.020 |
Why?
|
| Stromal Cells | 1 | 2017 | 1327 | 0.020 |
Why?
|
| Fetal Death | 1 | 1993 | 434 | 0.020 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 2 | 2006 | 330 | 0.020 |
Why?
|
| Ocular Motility Disorders | 1 | 1993 | 143 | 0.020 |
Why?
|
| Culture Media, Conditioned | 1 | 2013 | 522 | 0.020 |
Why?
|
| Extracellular Matrix | 1 | 1999 | 1726 | 0.020 |
Why?
|
| Therapy, Computer-Assisted | 1 | 1993 | 267 | 0.020 |
Why?
|
| Betaine-Homocysteine S-Methyltransferase | 1 | 2010 | 6 | 0.020 |
Why?
|
| Receptors, Vascular Endothelial Growth Factor | 2 | 2008 | 666 | 0.020 |
Why?
|
| Quality of Life | 2 | 2020 | 13300 | 0.020 |
Why?
|
| Reduced Folate Carrier Protein | 1 | 2010 | 9 | 0.020 |
Why?
|
| Neuropilin-1 | 1 | 2011 | 90 | 0.020 |
Why?
|
| Alcohol Drinking | 1 | 2004 | 4012 | 0.020 |
Why?
|
| Dimerization | 1 | 2013 | 890 | 0.020 |
Why?
|
| Light Coagulation | 1 | 1991 | 71 | 0.020 |
Why?
|
| Scapula | 1 | 1992 | 173 | 0.020 |
Why?
|
| Calcinosis | 1 | 2000 | 1478 | 0.020 |
Why?
|
| Penetrance | 2 | 2004 | 388 | 0.020 |
Why?
|
| 5-Methyltetrahydrofolate-Homocysteine S-Methyltransferase | 1 | 2010 | 28 | 0.020 |
Why?
|
| General Surgery | 1 | 2002 | 1681 | 0.020 |
Why?
|
| Immunophenotyping | 2 | 2006 | 1870 | 0.020 |
Why?
|
| Carbon-Nitrogen Ligases | 1 | 2010 | 27 | 0.020 |
Why?
|
| Famous Persons | 1 | 1972 | 109 | 0.020 |
Why?
|
| Homozygote | 1 | 1996 | 1786 | 0.020 |
Why?
|
| Blotting, Northern | 2 | 2003 | 1544 | 0.020 |
Why?
|
| Gene Library | 1 | 2014 | 1060 | 0.020 |
Why?
|
| Thymidylate Synthase | 1 | 2010 | 72 | 0.020 |
Why?
|
| Genital Diseases, Male | 1 | 2011 | 83 | 0.020 |
Why?
|
| Epinephrine | 1 | 2014 | 791 | 0.020 |
Why?
|
| Protein Transport | 2 | 2008 | 1966 | 0.020 |
Why?
|
| England | 2 | 1985 | 526 | 0.020 |
Why?
|
| Burns | 1 | 1982 | 1865 | 0.020 |
Why?
|
| Fibrin Tissue Adhesive | 1 | 2011 | 85 | 0.020 |
Why?
|
| Socioeconomic Factors | 1 | 2004 | 7803 | 0.020 |
Why?
|
| History, 18th Century | 2 | 1985 | 207 | 0.020 |
Why?
|
| Catalysis | 1 | 2012 | 775 | 0.020 |
Why?
|
| Cornea | 1 | 1998 | 1325 | 0.020 |
Why?
|
| Cysteine | 1 | 1995 | 897 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1998 | 1395 | 0.020 |
Why?
|
| Birth Injuries | 1 | 1992 | 150 | 0.020 |
Why?
|
| Conserved Sequence | 1 | 1993 | 1168 | 0.020 |
Why?
|
| Predictive Value of Tests | 2 | 2012 | 15273 | 0.020 |
Why?
|
| Sampling Studies | 1 | 2011 | 614 | 0.020 |
Why?
|
| Vasodilator Agents | 1 | 2014 | 977 | 0.020 |
Why?
|
| Clone Cells | 2 | 2006 | 1663 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2019 | 2861 | 0.020 |
Why?
|
| Carotid Arteries | 1 | 1994 | 951 | 0.020 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2005 | 3618 | 0.020 |
Why?
|
| Ribs | 2 | 1998 | 254 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2016 | 1972 | 0.020 |
Why?
|
| Choanal Atresia | 1 | 2009 | 40 | 0.020 |
Why?
|
| Pigmentation Disorders | 1 | 1990 | 105 | 0.020 |
Why?
|
| Bones of Upper Extremity | 1 | 2009 | 6 | 0.020 |
Why?
|
| Voice Quality | 1 | 2011 | 226 | 0.020 |
Why?
|
| Respiratory Function Tests | 1 | 2014 | 1684 | 0.020 |
Why?
|
| IgG Deficiency | 1 | 2009 | 29 | 0.020 |
Why?
|
| Neoplasm, Residual | 2 | 2010 | 1008 | 0.020 |
Why?
|
| Osseointegration | 1 | 2011 | 274 | 0.020 |
Why?
|
| Acrylic Resins | 1 | 1989 | 135 | 0.020 |
Why?
|
| Body Height | 1 | 2015 | 1570 | 0.020 |
Why?
|
| IgA Deficiency | 1 | 2009 | 43 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 2 | 2008 | 2056 | 0.020 |
Why?
|
| Peritoneal Neoplasms | 1 | 2015 | 706 | 0.020 |
Why?
|
| Phlebography | 1 | 2010 | 325 | 0.020 |
Why?
|
| Texas | 1 | 2010 | 401 | 0.020 |
Why?
|
| Tuberous Sclerosis | 1 | 1977 | 1030 | 0.020 |
Why?
|
| Pain | 2 | 2023 | 5066 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase Kinases | 1 | 2011 | 642 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2009 | 5039 | 0.020 |
Why?
|
| Dilatation, Pathologic | 1 | 2010 | 527 | 0.020 |
Why?
|
| Trigeminal Nerve | 1 | 1990 | 248 | 0.020 |
Why?
|
| Surgical Wound Infection | 2 | 2010 | 1529 | 0.020 |
Why?
|
| Fractures, Bone | 2 | 1977 | 2041 | 0.020 |
Why?
|
| Orthodontic Appliances, Removable | 1 | 1988 | 30 | 0.020 |
Why?
|
| Central Nervous System | 1 | 1995 | 1334 | 0.020 |
Why?
|
| Sequence Analysis, RNA | 1 | 2016 | 2003 | 0.020 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 1999 | 158 | 0.020 |
Why?
|
| Twins, Conjoined | 1 | 1987 | 41 | 0.020 |
Why?
|
| Pneumonia, Pneumococcal | 1 | 2009 | 131 | 0.020 |
Why?
|
| Embolism | 1 | 1971 | 408 | 0.020 |
Why?
|
| Antigens, Nuclear | 1 | 2008 | 184 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2009 | 2651 | 0.020 |
Why?
|
| Genome-Wide Association Study | 2 | 2017 | 12602 | 0.020 |
Why?
|
| Spinal Cord Compression | 1 | 2009 | 235 | 0.020 |
Why?
|
| COS Cells | 1 | 2009 | 1129 | 0.020 |
Why?
|
| Single-Chain Antibodies | 1 | 2008 | 111 | 0.020 |
Why?
|
| Mexico | 1 | 2010 | 760 | 0.020 |
Why?
|
| Nitric Oxide Synthase Type III | 1 | 2010 | 704 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2014 | 1295 | 0.020 |
Why?
|
| Antineoplastic Agents, Hormonal | 1 | 1996 | 1523 | 0.020 |
Why?
|
| Prognosis | 4 | 2013 | 29636 | 0.020 |
Why?
|
| History of Medicine | 2 | 1978 | 42 | 0.020 |
Why?
|
| Neoplasms, Second Primary | 1 | 2015 | 1060 | 0.020 |
Why?
|
| Arm Injuries | 1 | 2009 | 156 | 0.020 |
Why?
|
| Intestinal Obstruction | 1 | 1971 | 435 | 0.020 |
Why?
|
| Smoking | 1 | 2004 | 9070 | 0.020 |
Why?
|
| Vena Cava Filters | 1 | 2010 | 261 | 0.020 |
Why?
|
| Macroglossia | 1 | 1986 | 12 | 0.020 |
Why?
|
| Microvessels | 1 | 2011 | 572 | 0.020 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2008 | 186 | 0.020 |
Why?
|
| Protein Binding | 1 | 2019 | 9336 | 0.020 |
Why?
|
| Elephantiasis | 1 | 2006 | 11 | 0.020 |
Why?
|
| RNA, Untranslated | 1 | 2010 | 459 | 0.020 |
Why?
|
| Retinal Vessels | 1 | 2013 | 836 | 0.020 |
Why?
|
| Vascular Endothelial Growth Factors | 2 | 2001 | 749 | 0.020 |
Why?
|
| Mutant Proteins | 1 | 2008 | 492 | 0.020 |
Why?
|
| Apoptosis | 2 | 2005 | 9497 | 0.020 |
Why?
|
| Phylogeny | 1 | 2014 | 2775 | 0.020 |
Why?
|
| Zebrafish | 1 | 2018 | 2996 | 0.020 |
Why?
|
| Eye Neoplasms | 1 | 1988 | 306 | 0.020 |
Why?
|
| Angiokeratoma | 1 | 2006 | 5 | 0.020 |
Why?
|
| Transcriptional Activation | 1 | 2013 | 1755 | 0.020 |
Why?
|
| Cryosurgery | 1 | 1992 | 473 | 0.020 |
Why?
|
| Microcephaly | 1 | 1990 | 423 | 0.020 |
Why?
|
| Colombia | 1 | 2007 | 276 | 0.020 |
Why?
|
| Endothelium | 3 | 1986 | 764 | 0.020 |
Why?
|
| Boronic Acids | 1 | 2010 | 914 | 0.020 |
Why?
|
| Cell Transplantation | 1 | 2008 | 473 | 0.020 |
Why?
|
| Particle Size | 1 | 2010 | 1643 | 0.020 |
Why?
|
| Patient Care Planning | 1 | 2012 | 909 | 0.020 |
Why?
|
| Drug Evaluation, Preclinical | 1 | 2011 | 1346 | 0.020 |
Why?
|
| Lip Neoplasms | 1 | 1986 | 36 | 0.020 |
Why?
|
| Melanosis | 1 | 2007 | 93 | 0.020 |
Why?
|
| 17-Hydroxysteroid Dehydrogenases | 1 | 2005 | 55 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2011 | 1387 | 0.020 |
Why?
|
| Penicillin Resistance | 1 | 1985 | 82 | 0.020 |
Why?
|
| Endothelial Growth Factors | 2 | 2001 | 674 | 0.020 |
Why?
|
| Nerve Tissue Proteins | 1 | 1999 | 4409 | 0.020 |
Why?
|
| High-Throughput Screening Assays | 1 | 2011 | 943 | 0.020 |
Why?
|
| Infant Nutrition Disorders | 1 | 2006 | 71 | 0.020 |
Why?
|
| Lymphokines | 2 | 2001 | 929 | 0.020 |
Why?
|
| Case Management | 1 | 2007 | 273 | 0.020 |
Why?
|
| Clindamycin | 1 | 1985 | 140 | 0.020 |
Why?
|
| Pulse | 1 | 2005 | 218 | 0.020 |
Why?
|
| Hand | 2 | 2002 | 903 | 0.020 |
Why?
|
| Heparin | 1 | 1992 | 1655 | 0.020 |
Why?
|
| Powders | 1 | 1985 | 80 | 0.020 |
Why?
|
| Failure to Thrive | 1 | 2006 | 140 | 0.020 |
Why?
|
| History, 17th Century | 1 | 1985 | 107 | 0.020 |
Why?
|
| Pneumococcal Vaccines | 1 | 2009 | 397 | 0.020 |
Why?
|
| Tracheotomy | 1 | 2006 | 167 | 0.020 |
Why?
|
| Drug Combinations | 1 | 2011 | 2024 | 0.020 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 1991 | 708 | 0.020 |
Why?
|
| Algorithms | 4 | 2010 | 13967 | 0.020 |
Why?
|
| Strabismus | 1 | 2009 | 317 | 0.010 |
Why?
|
| Technetium | 2 | 2000 | 321 | 0.010 |
Why?
|
| Pyrazines | 1 | 2010 | 1200 | 0.010 |
Why?
|
| Organ Size | 1 | 2009 | 2249 | 0.010 |
Why?
|
| Microsurgery | 1 | 2009 | 791 | 0.010 |
Why?
|
| Vaccination | 1 | 1976 | 3360 | 0.010 |
Why?
|
| Age of Onset | 1 | 2011 | 3302 | 0.010 |
Why?
|
| Antigens, Surface | 1 | 2008 | 1616 | 0.010 |
Why?
|
| Jaw Relation Record | 1 | 2003 | 38 | 0.010 |
Why?
|
| Parents | 1 | 1998 | 3547 | 0.010 |
Why?
|
| Dental Arch | 1 | 2003 | 42 | 0.010 |
Why?
|
| Laser Therapy | 1 | 1991 | 1089 | 0.010 |
Why?
|
| Helix-Loop-Helix Motifs | 1 | 2003 | 96 | 0.010 |
Why?
|
| Counseling | 1 | 2012 | 1550 | 0.010 |
Why?
|
| Antigens, Neoplasm | 2 | 2006 | 1999 | 0.010 |
Why?
|
| X Chromosome Inactivation | 1 | 2006 | 226 | 0.010 |
Why?
|
| Antigens, CD34 | 1 | 2005 | 652 | 0.010 |
Why?
|
| Streptococcus pneumoniae | 1 | 2009 | 732 | 0.010 |
Why?
|
| Postoperative Care | 1 | 2010 | 1478 | 0.010 |
Why?
|
| Injections, Intravenous | 1 | 1985 | 1388 | 0.010 |
Why?
|
| Gastrostomy | 1 | 2006 | 321 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2006 | 434 | 0.010 |
Why?
|
| Occipital Lobe | 1 | 2005 | 373 | 0.010 |
Why?
|
| France | 1 | 2004 | 511 | 0.010 |
Why?
|
| Molecular Weight | 1 | 2005 | 2186 | 0.010 |
Why?
|
| Intermittent Claudication | 1 | 2005 | 305 | 0.010 |
Why?
|
| Cardiac Output, High | 1 | 2002 | 6 | 0.010 |
Why?
|
| Multivariate Analysis | 2 | 2012 | 12156 | 0.010 |
Why?
|
| Thoracic Neoplasms | 2 | 1997 | 265 | 0.010 |
Why?
|
| Antibodies, Bacterial | 1 | 2009 | 1470 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2004 | 410 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 2008 | 1135 | 0.010 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 2004 | 430 | 0.010 |
Why?
|
| Medicine | 1 | 2011 | 943 | 0.010 |
Why?
|
| Stress, Psychological | 1 | 1998 | 4440 | 0.010 |
Why?
|
| Infant Welfare | 1 | 2002 | 80 | 0.010 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 1705 | 0.010 |
Why?
|
| Genetic Diseases, X-Linked | 1 | 2006 | 378 | 0.010 |
Why?
|
| Palatal Neoplasms | 1 | 2002 | 37 | 0.010 |
Why?
|
| Traction | 1 | 1982 | 106 | 0.010 |
Why?
|
| Jaw Diseases | 1 | 1982 | 92 | 0.010 |
Why?
|
| Trachea | 1 | 1968 | 1082 | 0.010 |
Why?
|
| Polymorphism, Genetic | 3 | 1999 | 4286 | 0.010 |
Why?
|
| Monosaccharide Transport Proteins | 1 | 2003 | 440 | 0.010 |
Why?
|
| Culture Techniques | 1 | 1982 | 530 | 0.010 |
Why?
|
| Binding Sites | 1 | 2010 | 6050 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 2005 | 2262 | 0.010 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2011 | 2823 | 0.010 |
Why?
|
| Neoplasms | 2 | 2009 | 22066 | 0.010 |
Why?
|
| Codon, Terminator | 1 | 2002 | 125 | 0.010 |
Why?
|
| Constriction, Pathologic | 1 | 2005 | 1098 | 0.010 |
Why?
|
| Phosphate Transport Proteins | 1 | 2001 | 12 | 0.010 |
Why?
|
| Microradiography | 1 | 1980 | 13 | 0.010 |
Why?
|
| Chromosomes, Artificial, Yeast | 1 | 2001 | 113 | 0.010 |
Why?
|
| Anus, Imperforate | 1 | 2001 | 64 | 0.010 |
Why?
|
| Periodontal Diseases | 1 | 1984 | 452 | 0.010 |
Why?
|
| Zygomatic Fractures | 2 | 1977 | 35 | 0.010 |
Why?
|
| Aneuploidy | 1 | 2004 | 551 | 0.010 |
Why?
|
| Cell Line | 2 | 2009 | 15626 | 0.010 |
Why?
|
| Hyperkeratosis, Epidermolytic | 1 | 2000 | 7 | 0.010 |
Why?
|
| Angiopoietin-2 | 1 | 2001 | 173 | 0.010 |
Why?
|
| Enzyme Inhibitors | 1 | 2011 | 3726 | 0.010 |
Why?
|
| Transplantation, Isogeneic | 1 | 1980 | 248 | 0.010 |
Why?
|
| Bone Remodeling | 1 | 2004 | 580 | 0.010 |
Why?
|
| Conjunctivitis | 1 | 1981 | 155 | 0.010 |
Why?
|
| Treatment Failure | 2 | 1998 | 2646 | 0.010 |
Why?
|
| Osteoclasts | 1 | 2004 | 712 | 0.010 |
Why?
|
| Alopecia | 1 | 2005 | 415 | 0.010 |
Why?
|
| Freeze Drying | 1 | 1980 | 101 | 0.010 |
Why?
|
| Drug Implants | 1 | 1981 | 230 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9531 | 0.010 |
Why?
|
| Crohn Disease | 1 | 2013 | 2275 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1983 | 1765 | 0.010 |
Why?
|
| Core Binding Factors | 1 | 1999 | 29 | 0.010 |
Why?
|
| Enteral Nutrition | 1 | 2006 | 781 | 0.010 |
Why?
|
| Omentum | 1 | 1980 | 169 | 0.010 |
Why?
|
| Dogs | 1 | 1984 | 3843 | 0.010 |
Why?
|
| Parietal Lobe | 1 | 2005 | 850 | 0.010 |
Why?
|
| Bucladesine | 1 | 1999 | 118 | 0.010 |
Why?
|
| Psychomotor Disorders | 1 | 2000 | 149 | 0.010 |
Why?
|
| Microstomia | 1 | 1999 | 11 | 0.010 |
Why?
|
| Survival Rate | 1 | 2013 | 12806 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-2 | 1 | 1999 | 72 | 0.010 |
Why?
|
| Promoter Regions, Genetic | 1 | 2010 | 5784 | 0.010 |
Why?
|
| Tensile Strength | 1 | 1980 | 331 | 0.010 |
Why?
|
| Muscles | 2 | 1992 | 1581 | 0.010 |
Why?
|
| Orthopedic Fixation Devices | 1 | 1999 | 76 | 0.010 |
Why?
|
| Gutta-Percha | 1 | 1978 | 4 | 0.010 |
Why?
|
| Molecular Targeted Therapy | 1 | 2010 | 2805 | 0.010 |
Why?
|
| Infusions, Parenteral | 1 | 1979 | 404 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinase-1 | 1 | 1999 | 151 | 0.010 |
Why?
|
| Translocation, Genetic | 1 | 2004 | 1388 | 0.010 |
Why?
|
| Medical Records | 1 | 2004 | 1407 | 0.010 |
Why?
|
| Cluster Analysis | 1 | 2005 | 2698 | 0.010 |
Why?
|
| Polydactyly | 1 | 1999 | 56 | 0.010 |
Why?
|
| Open Reading Frames | 1 | 2002 | 814 | 0.010 |
Why?
|
| Salivary Gland Diseases | 1 | 1978 | 37 | 0.010 |
Why?
|
| Cytogenetic Analysis | 1 | 1999 | 271 | 0.010 |
Why?
|
| Codon | 1 | 2000 | 602 | 0.010 |
Why?
|
| Gene Expression Profiling | 2 | 2006 | 9388 | 0.010 |
Why?
|
| Electronic Health Records | 1 | 2015 | 4763 | 0.010 |
Why?
|
| Liver | 1 | 2014 | 7512 | 0.010 |
Why?
|
| Cell Count | 1 | 1982 | 1838 | 0.010 |
Why?
|
| Tooth | 1 | 1999 | 208 | 0.010 |
Why?
|
| Hemosiderin | 1 | 1997 | 41 | 0.010 |
Why?
|
| Europe | 1 | 1985 | 3433 | 0.010 |
Why?
|
| Actins | 1 | 2005 | 2049 | 0.010 |
Why?
|
| Epithelium | 1 | 1983 | 1605 | 0.010 |
Why?
|
| Tooth Fractures | 1 | 1977 | 28 | 0.010 |
Why?
|
| Sialadenitis | 1 | 1978 | 45 | 0.010 |
Why?
|
| Maxillary Fractures | 1 | 1977 | 21 | 0.010 |
Why?
|
| Choroid | 1 | 2000 | 349 | 0.010 |
Why?
|
| Body Mass Index | 1 | 2015 | 12901 | 0.010 |
Why?
|
| Ecchymosis | 1 | 1997 | 32 | 0.010 |
Why?
|
| Nuclear Family | 1 | 1999 | 313 | 0.010 |
Why?
|
| Cytosol | 1 | 2001 | 887 | 0.010 |
Why?
|
| Wound Infection | 1 | 1980 | 243 | 0.010 |
Why?
|
| Frameshift Mutation | 1 | 1999 | 388 | 0.010 |
Why?
|
| Animals, Newborn | 1 | 1983 | 2671 | 0.010 |
Why?
|
| Blotting, Southern | 1 | 1998 | 778 | 0.010 |
Why?
|
| Calcium | 2 | 1981 | 5726 | 0.010 |
Why?
|
| Somatoform Disorders | 1 | 2000 | 423 | 0.010 |
Why?
|
| Angiogenesis Inducing Agents | 1 | 1999 | 279 | 0.010 |
Why?
|
| Critical Care | 1 | 2010 | 2699 | 0.010 |
Why?
|
| Mandibular Fractures | 1 | 1977 | 76 | 0.010 |
Why?
|
| Cats | 1 | 1978 | 976 | 0.010 |
Why?
|
| Myopia | 1 | 1999 | 245 | 0.010 |
Why?
|
| Cross-Cultural Comparison | 1 | 2000 | 632 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2009 | 4546 | 0.010 |
Why?
|
| Luminescent Proteins | 1 | 1999 | 835 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1999 | 981 | 0.010 |
Why?
|
| Cyclic AMP-Dependent Protein Kinases | 1 | 1999 | 482 | 0.010 |
Why?
|
| Hand Injuries | 2 | 1979 | 239 | 0.010 |
Why?
|
| Blood Coagulation Disorders | 1 | 2000 | 349 | 0.010 |
Why?
|
| Genetic Testing | 1 | 2009 | 3530 | 0.010 |
Why?
|
| Pain, Postoperative | 1 | 2006 | 1718 | 0.010 |
Why?
|
| Bites, Human | 1 | 1975 | 10 | 0.010 |
Why?
|
| Lymphoid Tissue | 1 | 1997 | 446 | 0.010 |
Why?
|
| Regional Blood Flow | 1 | 1999 | 1490 | 0.010 |
Why?
|
| Japan | 1 | 2000 | 1369 | 0.010 |
Why?
|
| Iatrogenic Disease | 1 | 1979 | 538 | 0.010 |
Why?
|
| Triamcinolone | 1 | 1975 | 68 | 0.010 |
Why?
|
| Drug Resistance | 2 | 1992 | 1617 | 0.010 |
Why?
|
| RNA | 1 | 2005 | 2721 | 0.010 |
Why?
|
| Hyperplasia | 1 | 1999 | 1158 | 0.010 |
Why?
|
| Tomography, Emission-Computed, Single-Photon | 1 | 2000 | 1067 | 0.010 |
Why?
|
| Pheochromocytoma | 1 | 1998 | 328 | 0.010 |
Why?
|
| Ear Neoplasms | 1 | 1975 | 118 | 0.010 |
Why?
|
| Spinal Fusion | 1 | 1984 | 1280 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 2008 | 4938 | 0.010 |
Why?
|
| Bites and Stings | 1 | 1975 | 93 | 0.010 |
Why?
|
| Cell Line, Tumor | 1 | 2011 | 16905 | 0.010 |
Why?
|
| Bacteria | 1 | 1985 | 2196 | 0.010 |
Why?
|
| Immunoglobulins | 1 | 1998 | 863 | 0.010 |
Why?
|
| Blood Cell Count | 1 | 1995 | 398 | 0.010 |
Why?
|
| Glucosephosphate Dehydrogenase | 1 | 1975 | 210 | 0.010 |
Why?
|
| Body Image | 1 | 1979 | 634 | 0.010 |
Why?
|
| Anticoagulants | 1 | 2010 | 4896 | 0.010 |
Why?
|
| Tissue Inhibitor of Metalloproteinases | 1 | 1994 | 97 | 0.010 |
Why?
|
| Retroperitoneal Neoplasms | 1 | 1997 | 329 | 0.010 |
Why?
|
| Linear Models | 1 | 2004 | 5876 | 0.010 |
Why?
|
| Practice Guidelines as Topic | 1 | 2011 | 7468 | 0.010 |
Why?
|
| Liver Function Tests | 1 | 1995 | 524 | 0.010 |
Why?
|
| Ki-67 Antigen | 1 | 1996 | 631 | 0.010 |
Why?
|
| Hematopoietic Stem Cells | 1 | 2006 | 3390 | 0.010 |
Why?
|
| Collagenases | 1 | 1994 | 221 | 0.010 |
Why?
|
| Life Change Events | 1 | 1979 | 953 | 0.010 |
Why?
|
| Pressure | 1 | 1977 | 1155 | 0.010 |
Why?
|
| Proliferating Cell Nuclear Antigen | 1 | 1994 | 283 | 0.010 |
Why?
|
| Cerebral Infarction | 1 | 1998 | 982 | 0.010 |
Why?
|
| Eyelid Diseases | 1 | 1975 | 157 | 0.010 |
Why?
|
| Alanine Transaminase | 1 | 1975 | 607 | 0.010 |
Why?
|
| Movement | 1 | 1980 | 1474 | 0.010 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 1995 | 778 | 0.010 |
Why?
|
| Hypothermia, Induced | 1 | 1978 | 758 | 0.010 |
Why?
|
| Carbohydrate Sequence | 1 | 1992 | 410 | 0.010 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 1998 | 734 | 0.010 |
Why?
|
| Disseminated Intravascular Coagulation | 1 | 1992 | 187 | 0.010 |
Why?
|
| Peptides | 1 | 2003 | 4358 | 0.010 |
Why?
|
| Bone Density | 1 | 2004 | 3528 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1999 | 1798 | 0.010 |
Why?
|
| Mucous Membrane | 1 | 1994 | 657 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 1996 | 1526 | 0.010 |
Why?
|
| Recombinant Fusion Proteins | 1 | 1999 | 3735 | 0.010 |
Why?
|
| Matrix Metalloproteinase 9 | 1 | 1994 | 633 | 0.010 |
Why?
|
| Repetitive Sequences, Nucleic Acid | 1 | 1993 | 783 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 1996 | 3604 | 0.010 |
Why?
|
| Radiopharmaceuticals | 1 | 2000 | 2633 | 0.010 |
Why?
|
| Oligosaccharides | 1 | 1992 | 405 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1992 | 1746 | 0.010 |
Why?
|
| Hospitalization | 1 | 2010 | 10761 | 0.010 |
Why?
|
| Oligonucleotides | 1 | 1993 | 588 | 0.010 |
Why?
|
| Retina | 1 | 2000 | 2635 | 0.010 |
Why?
|
| Ileum | 1 | 1971 | 556 | 0.000 |
Why?
|
| Social Class | 1 | 1998 | 2005 | 0.000 |
Why?
|
| Posture | 1 | 1993 | 954 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1994 | 58947 | 0.000 |
Why?
|
| Peptide Fragments | 1 | 2001 | 5120 | 0.000 |
Why?
|
| Models, Molecular | 1 | 1998 | 5429 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 2005 | 11902 | 0.000 |
Why?
|
| Prednisone | 1 | 1992 | 1566 | 0.000 |
Why?
|
| Breast Neoplasms | 1 | 2015 | 21065 | 0.000 |
Why?
|
| Tracheal Diseases | 1 | 1968 | 115 | 0.000 |
Why?
|
| Mucopolysaccharidoses | 1 | 1986 | 27 | 0.000 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 1986 | 44 | 0.000 |
Why?
|
| Arteriosclerosis | 1 | 1971 | 1064 | 0.000 |
Why?
|
| Traumatology | 1 | 1987 | 94 | 0.000 |
Why?
|
| Ear Canal | 1 | 1985 | 146 | 0.000 |
Why?
|
| Technetium Tc 99m Medronate | 1 | 1984 | 131 | 0.000 |
Why?
|
| Anxiety | 1 | 1998 | 4532 | 0.000 |
Why?
|
| Swine | 1 | 1992 | 5902 | 0.000 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 1992 | 3764 | 0.000 |
Why?
|
| Muscular Diseases | 1 | 1986 | 551 | 0.000 |
Why?
|
| Tissue Preservation | 1 | 1982 | 174 | 0.000 |
Why?
|
| Cholesterol | 1 | 1971 | 2925 | 0.000 |
Why?
|
| Lung Neoplasms | 1 | 2005 | 13249 | 0.000 |
Why?
|
| Neurosurgery | 1 | 1987 | 670 | 0.000 |
Why?
|
| Interprofessional Relations | 1 | 1987 | 989 | 0.000 |
Why?
|
| Anti-Bacterial Agents | 2 | 1978 | 7400 | 0.000 |
Why?
|
| Radionuclide Imaging | 1 | 1984 | 1975 | 0.000 |
Why?
|
| Evaluation Studies as Topic | 1 | 1982 | 1628 | 0.000 |
Why?
|
| Alveolar Ridge Augmentation | 1 | 1982 | 208 | 0.000 |
Why?
|
| Otolaryngology | 1 | 1987 | 685 | 0.000 |
Why?
|
| Diphosphonates | 1 | 1984 | 638 | 0.000 |
Why?
|
| Liposarcoma | 1 | 1982 | 283 | 0.000 |
Why?
|
| Hypertonic Solutions | 1 | 1979 | 82 | 0.000 |
Why?
|
| Gait | 1 | 1984 | 812 | 0.000 |
Why?
|
| Parotitis | 1 | 1978 | 28 | 0.000 |
Why?
|
| Drainage | 1 | 1984 | 1161 | 0.000 |
Why?
|
| Cattle | 1 | 1984 | 3847 | 0.000 |
Why?
|
| Submandibular Gland | 1 | 1978 | 87 | 0.000 |
Why?
|
| Mandibular Injuries | 1 | 1977 | 20 | 0.000 |
Why?
|
| Maxillofacial Injuries | 1 | 1977 | 32 | 0.000 |
Why?
|
| Pregnancy Complications | 1 | 1991 | 2940 | 0.000 |
Why?
|
| Debridement | 1 | 1979 | 492 | 0.000 |
Why?
|
| Injections, Intradermal | 1 | 1975 | 116 | 0.000 |
Why?
|
| Fibroblasts | 1 | 1986 | 4091 | 0.000 |
Why?
|
| Cellulitis | 1 | 1975 | 208 | 0.000 |
Why?
|
| Communication | 1 | 1987 | 3846 | 0.000 |
Why?
|
| Doxorubicin | 1 | 1979 | 2207 | 0.000 |
Why?
|
| Abscess | 1 | 1975 | 605 | 0.000 |
Why?
|
| Quality of Health Care | 1 | 1987 | 4361 | 0.000 |
Why?
|
| Sarcoma | 1 | 1982 | 1786 | 0.000 |
Why?
|
| Macrophages | 1 | 1986 | 5745 | 0.000 |
Why?
|
| DNA, Neoplasm | 1 | 1975 | 1745 | 0.000 |
Why?
|
| Breast | 1 | 1979 | 1980 | 0.000 |
Why?
|
| Microbial Sensitivity Tests | 1 | 1975 | 1952 | 0.000 |
Why?
|
| Bacterial Infections | 1 | 1975 | 1402 | 0.000 |
Why?
|
| Acute Disease | 1 | 1978 | 7268 | 0.000 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 1982 | 4024 | 0.000 |
Why?
|
| Chronic Disease | 1 | 1978 | 9283 | 0.000 |
Why?
|